| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-20 | 2009-09-30 | 13F-HR | California State Teachers Retirement System | Institution | 197,239 | Sold Some | -25 | -0.01 % | $4,378,706 | $4,378,706 | $0 | 0.00 % | $0 | | | | | | News Article | History of California State Teachers Retirement System Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-20 | 2009-09-30 | N-Q | Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund | Small-Cap Core | | Sold All | -160,366 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-18 | 2009-09-30 | 13F-HR | Royal Bank Of Canada Trust Co Ltd | Institution | 23 | No Change | 0 | 0 % | $522 | $511 | $-11 | -2.15 % | $0 | | | | | | News Article | History of Royal Bank Of Canada Trust Co Ltd Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-18 | 2009-09-30 | 13F-HR | Timber Hill Llc | No Data | 24,754 | New Holding | 24,754 | 100 % | $561,668 | $549,539 | $-12,129 | -2.15 % | $-12,129 | | | | | | News Article | History of Timber Hill Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 566,440 | Sold Some | -221,641 | -28.12 % | $12,948,818 | $12,574,968 | $-373,850 | -2.88 % | $146,283 | | | | | | News Article | History of Amvescap Plc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | 458,903 | Sold Some | -113,511 | -19.83 % | $10,490,523 | $10,187,647 | $-302,876 | -2.88 % | $74,917 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Roxbury Capital Management | Institution | 195 | No Change | 0 | 0 % | $4,458 | $4,329 | $-129 | -2.88 % | $0 | | | | | | News Article | History of Roxbury Capital Management Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 917,636 | Sold Some | -29,014 | -3.06 % | $20,977,159 | $20,371,519 | $-605,640 | -2.88 % | $19,149 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Algert Coldiron Investors Llc | Institution | | Sold All | -85,880 | -100 % | | | | -3.93 % | $78,151 | | | | | | News Article | History of Algert Coldiron Investors Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 317,102 | Sold Some | -102,288 | -24.38 % | $7,328,227 | $7,039,664 | $-288,563 | -3.93 % | $93,082 | | | | | | News Article | History of American International Group Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Aqr Capital Management Llc | Institution | 389,102 | Sold Some | -46,274 | -10.62 % | $8,992,147 | $8,638,064 | $-354,083 | -3.93 % | $42,109 | | | | | | News Article | History of Aqr Capital Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Argyll Research Llc | Institution | 6,000 | New Holding | 6,000 | 100 % | $138,660 | $133,200 | $-5,460 | -3.93 % | $-5,460 | | | | | | News Article | History of Argyll Research Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Balyasny Asset Management Llc | Institution | 50,000 | New Holding | 50,000 | 100 % | $1,155,500 | $1,110,000 | $-45,500 | -3.93 % | $-45,500 | | | | | | News Article | History of Balyasny Asset Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bogle Investment Management L P | Institution | 16,900 | Sold Some | -102,900 | -85.89 % | $390,559 | $375,180 | $-15,379 | -3.93 % | $93,639 | | | | | | News Article | History of Bogle Investment Management L P Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Capital Research Global Investors | Institution | 6,253,100 | New Holding | 6,253,100 | 100 % | $144,509,141 | $138,818,820 | $-5,690,321 | -3.93 % | $-5,690,321 | | | | | | News Article | History of Capital Research Global Investors Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Catapult Capital Management Llc | Institution | 142,830 | New Holding | 142,830 | 100 % | $3,300,801 | $3,170,826 | $-129,975 | -3.93 % | $-129,975 | | | | | | News Article | History of Catapult Capital Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 40,106 | Sold Some | -51,267 | -56.10 % | $926,850 | $890,353 | $-36,496 | -3.93 % | $46,653 | | | | | | News Article | History of Citadel L P Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Columbia Partners L L C Investment Management | Institution | 35,250 | Sold Some | -213 | -0.60 % | $814,628 | $782,550 | $-32,078 | -3.93 % | $194 | | | | | | News Article | History of Columbia Partners L L C Investment Management Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Connor Clark And Lunn Investment Management Ltd | Institution | 31,800 | Added More | 1,500 | 4.95 % | $734,898 | $705,960 | $-28,938 | -3.93 % | $-1,365 | | | | | | News Article | History of Connor Clark And Lunn Investment Management Ltd Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Cr Intrinsic Investors Llc | Institution | | Sold All | -125,000 | -100 % | | | | -3.93 % | $113,750 | | | | | | News Article | History of Cr Intrinsic Investors Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Eaton Vance Management | Institution | 25,400 | Added More | 4,448 | 21.22 % | $586,994 | $563,880 | $-23,114 | -3.93 % | $-4,048 | | | | | | News Article | History of Eaton Vance Management Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Employees Retirement System Of Texas | Institution | 46,000 | No Change | 0 | 0 % | $1,063,060 | $1,021,200 | $-41,860 | -3.93 % | $0 | | | | | | News Article | History of Employees Retirement System Of Texas Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Enceladus Investment Management Llc | Institution | 123,950 | Sold Some | -200 | -0.16 % | $2,864,485 | $2,751,690 | $-112,795 | -3.93 % | $182 | | | | | | News Article | History of Enceladus Investment Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Epoch Investment Partners Inc | Institution | 3,355,782 | Added More | 1,037,875 | 44.77 % | $77,552,122 | $74,498,360 | $-3,053,762 | -3.93 % | $-944,466 | | | | | | News Article | History of Epoch Investment Partners Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fidelity International Ltd | Institution | | Sold All | -36,100 | -100 % | | | | -3.93 % | $32,851 | | | | | | News Article | History of Fidelity International Ltd Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fifth Third Bancorp | Institution | 5,200 | No Change | 0 | 0 % | $120,172 | $115,440 | $-4,732 | -3.93 % | $0 | | | | | | News Article | History of Fifth Third Bancorp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 10,557,599 | Sold Some | -976,557 | -8.46 % | $243,986,113 | $234,378,698 | $-9,607,415 | -3.93 % | $888,667 | | | | | | News Article | History of Fmr Corp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Fuller And Thaler Asset Management Inc | Institution | 200 | Sold Some | -200 | -50.00 % | $4,622 | $4,440 | $-182 | -3.93 % | $182 | | | | | | News Article | History of Fuller And Thaler Asset Management Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Icahn Capital Lp | Institution | | Sold All | -1,129,126 | -100 % | | | | -3.93 % | $1,027,505 | | | | | | News Article | History of Icahn Capital Lp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ing Groep Nv | Institution | 348,494 | Added More | 73,764 | 26.84 % | $8,053,696 | $7,736,567 | $-317,130 | -3.93 % | $-67,125 | | | | | | News Article | History of Ing Groep Nv Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Julius Baer Investment Management Llc | Institution | | Sold All | -6,020 | -100 % | | | | -3.93 % | $5,478 | | | | | | News Article | History of Julius Baer Investment Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Loomis Sayles And Co L P | Institution | 534,500 | Added More | 1,507 | 0.28 % | $12,352,295 | $11,865,900 | $-486,395 | -3.93 % | $-1,371 | | | | | | News Article | History of Loomis Sayles And Co L P Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Madison Square Investors Llc | No Data | 544,152 | Added More | 142,832 | 35.59 % | $12,575,353 | $12,080,174 | $-495,178 | -3.93 % | $-129,977 | | | | | | News Article | History of Madison Square Investors Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | 323,178 | Sold Some | -455,835 | -58.51 % | $7,468,644 | $7,174,552 | $-294,092 | -3.93 % | $414,810 | | | | | | News Article | History of Millennium Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 1,514,220 | Added More | 170,409 | 12.68 % | $34,993,624 | $33,615,684 | $-1,377,940 | -3.93 % | $-155,072 | | | | | | News Article | History of Morgan Stanley Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | New York State Teachers Retirement System | Institution | 214,100 | New Holding | 214,100 | 100 % | $4,947,851 | $4,753,020 | $-194,831 | -3.93 % | $-194,831 | | | | | | News Article | History of New York State Teachers Retirement System Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Co Of Connecticut | Institution | | Sold All | -95,393 | -100 % | | | | -3.93 % | $86,808 | | | | | | News Article | History of Northern Trust Co Of Connecticut Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 778,269 | Added More | 6,893 | 0.89 % | $17,985,797 | $17,277,572 | $-708,225 | -3.93 % | $-6,273 | | | | | | News Article | History of Northern Trust Corp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Nyl Trust Co | Institution | 21,973 | Sold Some | -9,744 | -30.72 % | $507,796 | $487,801 | $-19,995 | -3.93 % | $8,867 | | | | | | News Article | History of Nyl Trust Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | 230,579 | Sold Some | -311,901 | -57.49 % | $5,328,681 | $5,118,854 | $-209,827 | -3.93 % | $283,830 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Orbimed Advisors Llc | Institution | 3,441,900 | Added More | 2,578,100 | 298.46 % | $79,542,309 | $76,410,180 | $-3,132,129 | -3.93 % | $-2,346,071 | | | | | | News Article | History of Orbimed Advisors Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Oss Capital Management | Institution | 1,550,000 | Sold Some | -357,700 | -18.75 % | $35,820,500 | $34,410,000 | $-1,410,500 | -3.93 % | $325,507 | | | | | | News Article | History of Oss Capital Management Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Passport Management Llc | Institution | | Sold All | -230,000 | -100 % | | | | -3.93 % | $209,300 | | | | | | News Article | History of Passport Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Perceptive Advisors Llc | Institution | 180,000 | Added More | 130,000 | 260.00 % | $4,159,800 | $3,996,000 | $-163,800 | -3.93 % | $-118,300 | | | | | | News Article | History of Perceptive Advisors Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Pgqs Im Lp | No Data | 30,633 | New Holding | 30,633 | 100 % | $707,929 | $680,053 | $-27,876 | -3.93 % | $-27,876 | | | | | | News Article | History of Pgqs Im Lp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Rbc Dominion Securities Inc | Institution | 28,407 | Added More | 1,737 | 6.51 % | $656,486 | $630,635 | $-25,850 | -3.93 % | $-1,581 | | | | | | News Article | History of Rbc Dominion Securities Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Sac Capital Advisors Lp | No Data | 18,881 | Sold Some | -2,929 | -13.42 % | $436,340 | $419,158 | $-17,182 | -3.93 % | $2,665 | | | | | | News Article | History of Sac Capital Advisors Lp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | 8,782,776 | Sold Some | -2,745,654 | -23.81 % | $202,969,953 | $194,977,627 | $-7,992,326 | -3.93 % | $2,498,545 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Silvercrest Asset Management Group Llc | Institution | 32,000 | No Change | 0 | 0 % | $739,520 | $710,400 | $-29,120 | -3.93 % | $0 | | | | | | News Article | History of Silvercrest Asset Management Group Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Soros Fund Management Llc | Institution | 18,300 | New Holding | 18,300 | 100 % | $422,913 | $406,260 | $-16,653 | -3.93 % | $-16,653 | | | | | | News Article | History of Soros Fund Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | State Treasurer State Of Michigan | Institution | 74,200 | Sold Some | -1,200 | -1.59 % | $1,714,762 | $1,647,240 | $-67,522 | -3.93 % | $1,092 | | | | | | News Article | History of State Treasurer State Of Michigan Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Thales Fund Management Llc | Institution | | Sold All | -1,378 | -100 % | | | | -3.93 % | $1,254 | | | | | | News Article | History of Thales Fund Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Two Sigma Investments Llc | Institution | 32,078 | Sold Some | -49,617 | -60.73 % | $741,323 | $712,132 | $-29,191 | -3.93 % | $45,151 | | | | | | News Article | History of Two Sigma Investments Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ubs Global Asset Management Americas Inc | Institution | 28,007 | New Holding | 28,007 | 100 % | $647,242 | $621,755 | $-25,486 | -3.93 % | $-25,486 | | | | | | News Article | History of Ubs Global Asset Management Americas Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 100 | Sold Some | -575 | -85.18 % | $2,311 | $2,220 | $-91 | -3.93 % | $523 | | | | | | News Article | History of Us Bancorp De Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Vicis Capital Llc | Institution | 1,028,267 | Added More | 825,646 | 407.48 % | $23,763,250 | $22,827,527 | $-935,723 | -3.93 % | $-751,338 | | | | | | News Article | History of Vicis Capital Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Visium Asset Management Llc | Institution | 10,800 | No Change | 0 | 0 % | $249,588 | $239,760 | $-9,828 | -3.93 % | $0 | | | | | | News Article | History of Visium Asset Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wellington Management Co Llp | Institution | 855,650 | Sold Some | -9,344 | -1.08 % | $19,774,072 | $18,995,430 | $-778,642 | -3.93 % | $8,503 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-11-13 | 13F-HR | Wilmington Trust Co | Institution | 8,467 | Sold Some | -2,075 | -19.68 % | $192,201 | $187,967 | $-4,234 | -2.20 % | $1,038 | | | | | | News Article | History of Wilmington Trust Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-11-13 | 13F-HR | Wilmington Trust Fsb | Institution | 10,517 | Sold Some | -1,697 | -13.89 % | $238,736 | $233,477 | $-5,259 | -2.20 % | $849 | | | | | | News Article | History of Wilmington Trust Fsb Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-10-31 | 13F-HR | Peak6 Investments L P | Institution | | Sold All | -12,000 | -100 % | | | | -2.20 % | $6,000 | | | | | | News Article | History of Peak6 Investments L P Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 212,225 | Sold Some | -73,908 | -25.82 % | $4,817,508 | $4,711,395 | $-106,113 | -2.20 % | $36,954 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 1,972,431 | Added More | 39,862 | 2.06 % | $44,774,184 | $43,787,968 | $-986,216 | -2.20 % | $-19,931 | | | | | | News Article | History of Axa Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bank Of Albuquerque Na | No Data | 18,565 | Added More | 4,280 | 29.96 % | $421,426 | $412,143 | $-9,283 | -2.20 % | $-2,140 | | | | | | News Article | History of Bank Of Albuquerque Na Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bank Of Oklahoma National Association | No Data | 43,070 | Sold Some | -1,640 | -3.66 % | $977,689 | $956,154 | $-21,535 | -2.20 % | $820 | | | | | | News Article | History of Bank Of Oklahoma National Association Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 751,291 | Sold Some | -225,356 | -23.07 % | $17,054,306 | $16,678,660 | $-375,646 | -2.20 % | $112,678 | | | | | | News Article | History of Barclays Plc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Batterymarch Financial Management Inc | Institution | 1,337,337 | Sold Some | -143,093 | -9.66 % | $30,357,550 | $29,688,881 | $-668,669 | -2.20 % | $71,547 | | | | | | News Article | History of Batterymarch Financial Management Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | 65,403 | Added More | 7,820 | 13.58 % | $1,484,648 | $1,451,947 | $-32,702 | -2.20 % | $-3,910 | | | | | | News Article | History of Bnp Paribas Arbitrage Sa Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Brandywine Asset Management Llc | Institution | 232,600 | Added More | 87,160 | 59.92 % | $5,280,020 | $5,163,720 | $-116,300 | -2.20 % | $-43,580 | | | | | | News Article | History of Brandywine Asset Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Caxton Associates Llc | Institution | 70,946 | New Holding | 70,946 | 100 % | $1,610,474 | $1,575,001 | $-35,473 | -2.20 % | $-35,473 | | | | | | News Article | History of Caxton Associates Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Clearbridge Advisors Llc | Institution | 6,140 | Sold Some | -590 | -8.76 % | $139,378 | $136,308 | $-3,070 | -2.20 % | $295 | | | | | | News Article | History of Clearbridge Advisors Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Dekabank Deutsche Girozentrale | No Data | 90,137 | No Change | 0 | 0 % | $2,046,110 | $2,001,041 | $-45,069 | -2.20 % | $0 | | | | | | News Article | History of Dekabank Deutsche Girozentrale Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Expo Capital Management Llc | Institution | 210,000 | New Holding | 210,000 | 100 % | $4,767,000 | $4,662,000 | $-105,000 | -2.20 % | $-105,000 | | | | | | News Article | History of Expo Capital Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Fiduciary Asset Management Co | Institution | 23,900 | Sold Some | -75,700 | -76.00 % | $542,530 | $530,580 | $-11,950 | -2.20 % | $37,850 | | | | | | News Article | History of Fiduciary Asset Management Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | First Mercantile Trust Co | Institution | 30,950 | No Change | 0 | 0 % | $702,565 | $687,090 | $-15,475 | -2.20 % | $0 | | | | | | News Article | History of First Mercantile Trust Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 6,857 | Sold Some | -310,057 | -97.83 % | $155,654 | $152,225 | $-3,429 | -2.20 % | $155,029 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 277,701 | Added More | 17,127 | 6.57 % | $6,303,813 | $6,164,962 | $-138,851 | -2.20 % | $-8,564 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 134,322 | Sold Some | -81,461 | -37.75 % | $3,049,109 | $2,981,948 | $-67,161 | -2.20 % | $40,731 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Grantham Mayo Van Otterloo And Co Llc | Institution | 53,000 | Added More | 24,000 | 82.75 % | $1,203,100 | $1,176,600 | $-26,500 | -2.20 % | $-12,000 | | | | | | News Article | History of Grantham Mayo Van Otterloo And Co Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Hbk Investments L P | Institution | 29,525 | Added More | 11,525 | 64.02 % | $670,218 | $655,455 | $-14,763 | -2.20 % | $-5,763 | | | | | | News Article | History of Hbk Investments L P Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jacobs Levy Equity Management Inc | Institution | 47,600 | Sold Some | -176,300 | -78.74 % | $1,080,520 | $1,056,720 | $-23,800 | -2.20 % | $88,150 | | | | | | News Article | History of Jacobs Levy Equity Management Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jefferies Group Inc | Institution | 19,621 | New Holding | 19,621 | 100 % | $445,397 | $435,586 | $-9,811 | -2.20 % | $-9,811 | | | | | | News Article | History of Jefferies Group Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | King Investment Advisors Inc | Institution | 604,145 | Added More | 4,365 | 0.72 % | $13,714,092 | $13,412,019 | $-302,073 | -2.20 % | $-2,183 | | | | | | News Article | History of King Investment Advisors Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Knight Capital Group Inc | Institution | | Sold All | -58,862 | -100 % | | | | -2.20 % | $29,431 | | | | | | News Article | History of Knight Capital Group Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Legg Mason Capital Management Inc | Institution | 594 | New Holding | 594 | 100 % | $13,484 | $13,187 | $-297 | -2.20 % | $-297 | | | | | | News Article | History of Legg Mason Capital Management Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Legg Mason Inc | Institution | 1,200 | New Holding | 1,200 | 100 % | $27,240 | $26,640 | $-600 | -2.20 % | $-600 | | | | | | News Article | History of Legg Mason Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Legg Mason Investment Counsel Llc | Institution | 1,550 | No Change | 0 | 0 % | $35,185 | $34,410 | $-775 | -2.20 % | $0 | | | | | | News Article | History of Legg Mason Investment Counsel Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Los Angeles Capital Management And Equity Research Inc | Institution | 123,944 | New Holding | 123,944 | 100 % | $2,813,529 | $2,751,557 | $-61,972 | -2.20 % | $-61,972 | | | | | | News Article | History of Los Angeles Capital Management And Equity Research Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Managed Account Advisors Llc | Institution | 33,048 | Added More | 20,320 | 159.64 % | $750,190 | $733,666 | $-16,524 | -2.20 % | $-10,160 | | | | | | News Article | History of Managed Account Advisors Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Martingale Asset Management L P | Institution | 48,729 | Sold Some | -71,536 | -59.48 % | $1,106,148 | $1,081,784 | $-24,365 | -2.20 % | $35,768 | | | | | | News Article | History of Martingale Asset Management L P Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Mason Street Advisors Llc | Institution | 49,400 | Sold Some | -600 | -1.20 % | $1,121,380 | $1,096,680 | $-24,700 | -2.20 % | $300 | | | | | | News Article | History of Mason Street Advisors Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | N-Q | Met Investors Series Trust - Batterymarch Growth And Income Portfolio | Multi-Cap Growth | 70,700 | No Change | 0 | 0 % | $1,604,890 | $1,569,540 | $-35,350 | -2.20 % | $0 | | | | | | News Article | History of Met Investors Series Trust - Batterymarch Growth And Income Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | Neuberger Berman Group Llc | No Data | | Sold All | -11,052 | -100 % | | | | -2.20 % | $5,526 | | | | | | News Article | History of Neuberger Berman Group Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | New York State Common Retirement Fund | Institution | 513,400 | Sold Some | -32,000 | -5.86 % | $11,654,180 | $11,397,480 | $-256,700 | -2.20 % | $16,000 | | | | | | News Article | History of New York State Common Retirement Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Northwestern Mutual Wealth Management Co | Institution | 441 | No Change | 0 | 0 % | $10,011 | $9,790 | $-221 | -2.20 % | $0 | | | | | | News Article | History of Northwestern Mutual Wealth Management Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Oppenheimer And Co Inc | Institution | 11,154 | Sold Some | -650 | -5.50 % | $253,196 | $247,619 | $-5,577 | -2.20 % | $325 | | | | | | News Article | History of Oppenheimer And Co Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Panagora Asset Management Inc | Institution | 55,208 | Sold Some | -28,366 | -33.94 % | $1,253,222 | $1,225,618 | $-27,604 | -2.20 % | $14,183 | | | | | | News Article | History of Panagora Asset Management Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Perkins Investment Management Llc | No Data | 1,693,967 | Sold Some | -20,406 | -1.19 % | $38,453,051 | $37,606,067 | $-846,984 | -2.20 % | $10,203 | | | | | | News Article | History of Perkins Investment Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Pilot Advisors Lp | Institution | 861,050 | New Holding | 861,050 | 100 % | $19,545,835 | $19,115,310 | $-430,525 | -2.20 % | $-430,525 | | | | | | News Article | History of Pilot Advisors Lp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Price T Rowe Associates Inc | Institution | 34,619 | Added More | 900 | 2.66 % | $785,851 | $768,542 | $-17,310 | -2.20 % | $-450 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rainier Investment Management Inc | Institution | | Sold All | -1,659,716 | -100 % | | | | -2.20 % | $829,858 | | | | | | News Article | History of Rainier Investment Management Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Capital Markets Arbitrage S A | Institution | 4,047 | Sold Some | -40,955 | -91.00 % | $91,867 | $89,843 | $-2,024 | -2.20 % | $20,478 | | | | | | News Article | History of Rbc Capital Markets Arbitrage S A Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 3,057 | Sold Some | -1,204 | -28.25 % | $69,394 | $67,865 | $-1,529 | -2.20 % | $602 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Private Counsel Usa Inc | Institution | 1,075 | Added More | 331 | 44.48 % | $24,403 | $23,865 | $-538 | -2.20 % | $-166 | | | | | | News Article | History of Rbc Private Counsel Usa Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | | Sold All | -1,278,293 | -100 % | | | | -2.20 % | $639,147 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | Research Affiliates Llc | Institution | 75,713 | Added More | 980 | 1.31 % | $1,718,685 | $1,680,829 | $-37,857 | -2.20 % | $-490 | | | | | | News Article | History of Research Affiliates Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Scopia Management Inc | Institution | 470,097 | Added More | 194,271 | 70.43 % | $10,671,202 | $10,436,153 | $-235,049 | -2.20 % | $-97,136 | | | | | | News Article | History of Scopia Management Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sentinel Asset Management Inc | Institution | 28,130 | No Change | 0 | 0 % | $638,551 | $624,486 | $-14,065 | -2.20 % | $0 | | | | | | News Article | History of Sentinel Asset Management Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Spark Lp | Institution | | Sold All | -19,300 | -100 % | | | | -2.20 % | $9,650 | | | | | | News Article | History of Spark Lp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Thompson Siegel And Walmsley Inc | Institution | 638,913 | New Holding | 638,913 | 100 % | $14,503,325 | $14,183,869 | $-319,457 | -2.20 % | $-319,457 | | | | | | News Article | History of Thompson Siegel And Walmsley Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Tudor Investment Corp Et Al | Institution | 20,650 | New Holding | 20,650 | 100 % | $468,755 | $458,430 | $-10,325 | -2.20 % | $-10,325 | | | | | | News Article | History of Tudor Investment Corp Et Al Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 4,208,634 | Added More | 52,835 | 1.27 % | $95,535,992 | $93,431,675 | $-2,104,317 | -2.20 % | $-26,418 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Allianz Global Investors Of America L P | Institution | 18,900 | New Holding | 18,900 | 100 % | $424,116 | $419,580 | $-4,536 | -1.06 % | $-4,536 | | | | | | News Article | History of Allianz Global Investors Of America L P Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Allstate Insurance Co | Institution | 26,303 | Added More | 3,616 | 15.93 % | $590,239 | $583,927 | $-6,313 | -1.06 % | $-868 | | | | | | News Article | History of Allstate Insurance Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | American Assets Investment Management Llc | Institution | 30,000 | No Change | 0 | 0 % | $673,200 | $666,000 | $-7,200 | -1.06 % | $0 | | | | | | News Article | History of American Assets Investment Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Analytic Investors Inc | Institution | 21,563 | Sold Some | -4,626 | -17.66 % | $483,874 | $478,699 | $-5,175 | -1.06 % | $1,110 | | | | | | News Article | History of Analytic Investors Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Aronson And Johnson And Ortiz Lp | Institution | 2,664,100 | Sold Some | -171,600 | -6.05 % | $59,782,404 | $59,143,020 | $-639,384 | -1.06 % | $41,184 | | | | | | News Article | History of Aronson And Johnson And Ortiz Lp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bank Of America Corp | Institution | 1,602,705 | Added More | 187,155 | 13.22 % | $35,964,700 | $35,580,051 | $-384,649 | -1.06 % | $-44,917 | | | | | | News Article | History of Bank Of America Corp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 6,798,482 | Added More | 468,408 | 7.39 % | $152,557,936 | $150,926,300 | $-1,631,636 | -1.06 % | $-112,418 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 6,798,482 | Added More | 204,538 | 3.10 % | $152,557,936 | $150,926,300 | $-1,631,636 | -1.06 % | $-49,089 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Chicago Equity Partners Llc | Institution | 93,065 | Sold Some | -4,060 | -4.18 % | $2,088,379 | $2,066,043 | $-22,336 | -1.06 % | $974 | | | | | | News Article | History of Chicago Equity Partners Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Clark Estates Inc | Institution | 60,205 | Added More | 9,955 | 19.81 % | $1,351,000 | $1,336,551 | $-14,449 | -1.06 % | $-2,389 | | | | | | News Article | History of Clark Estates Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Claymore Advisors Llc | Institution | 33,499 | Sold Some | -3,740 | -10.04 % | $751,718 | $743,678 | $-8,040 | -1.06 % | $898 | | | | | | News Article | History of Claymore Advisors Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 32,178 | New Holding | 32,178 | 100 % | $722,074 | $714,352 | $-7,723 | -1.06 % | $-7,723 | | | | | | News Article | History of Credit Suisse Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Davidson D A And Co | Institution | 43 | No Change | 0 | 0 % | $965 | $955 | $-10 | -1.06 % | $0 | | | | | | News Article | History of Davidson D A And Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Davidson Investment Advisors | Institution | 43 | New Holding | 43 | 100 % | $965 | $955 | $-10 | -1.06 % | $-10 | | | | | | News Article | History of Davidson Investment Advisors Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Delphi Management Inc | Institution | 140,309 | No Change | 0 | 0 % | $3,148,534 | $3,114,860 | $-33,674 | -1.06 % | $0 | | | | | | News Article | History of Delphi Management Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Duquesne Capital Management L L C | Institution | | Sold All | -145,700 | -100 % | | | | -1.06 % | $34,968 | | | | | | News Article | History of Duquesne Capital Management L L C Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | First Quadrant L P | Institution | 369,216 | Added More | 319,416 | 641.39 % | $8,285,207 | $8,196,595 | $-88,612 | -1.06 % | $-76,660 | | | | | | News Article | History of First Quadrant L P Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | First Trust Advisors Lp | Institution | 675,031 | Added More | 164,698 | 32.27 % | $15,147,696 | $14,985,688 | $-162,007 | -1.06 % | $-39,528 | | | | | | News Article | History of First Trust Advisors Lp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Franklin Resources Inc | Institution | 41,600 | Sold Some | -585 | -1.38 % | $933,504 | $923,520 | $-9,984 | -1.06 % | $140 | | | | | | News Article | History of Franklin Resources Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Freeman Investment Management Co Llc | No Data | | Sold All | -56,350 | -100 % | | | | -1.06 % | $13,524 | | | | | | News Article | History of Freeman Investment Management Co Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Globeflex Capital L P | Institution | 43,900 | Sold Some | -14,500 | -24.82 % | $985,116 | $974,580 | $-10,536 | -1.06 % | $3,480 | | | | | | News Article | History of Globeflex Capital L P Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Gsa Capital Partners Llp | Institution | | Sold All | -12,051 | -100 % | | | | -1.06 % | $2,892 | | | | | | News Article | History of Gsa Capital Partners Llp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Hillsdale Investment Management Inc | Institution | 400 | New Holding | 400 | 100 % | $8,976 | $8,880 | $-96 | -1.06 % | $-96 | | | | | | News Article | History of Hillsdale Investment Management Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Icon Advisers Inc | Institution | 49,000 | New Holding | 49,000 | 100 % | $1,099,560 | $1,087,800 | $-11,760 | -1.06 % | $-11,760 | | | | | | News Article | History of Icon Advisers Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 259,730 | Added More | 6,700 | 2.64 % | $5,828,341 | $5,766,006 | $-62,335 | -1.06 % | $-1,608 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Kbc Group Nv | Institution | 65,819 | Sold Some | -53,359 | -44.77 % | $1,476,978 | $1,461,182 | $-15,797 | -1.06 % | $12,806 | | | | | | News Article | History of Kbc Group Nv Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Levin Capital Strategies L P | Institution | | Sold All | -20,000 | -100 % | | | | -1.06 % | $4,800 | | | | | | News Article | History of Levin Capital Strategies L P Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Lsv Asset Management | Institution | 5,521,118 | Added More | 78,003 | 1.43 % | $123,893,888 | $122,568,820 | $-1,325,068 | -1.06 % | $-18,721 | | | | | | News Article | History of Lsv Asset Management Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mccarthy Group Advisors Llc | Institution | 167,250 | Added More | 6,650 | 4.14 % | $3,753,090 | $3,712,950 | $-40,140 | -1.06 % | $-1,596 | | | | | | News Article | History of Mccarthy Group Advisors Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 1,529,061 | Added More | 138,092 | 9.92 % | $34,312,129 | $33,945,154 | $-366,975 | -1.06 % | $-33,142 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 208,645 | Added More | 1,838 | 0.88 % | $4,681,994 | $4,631,919 | $-50,075 | -1.06 % | $-441 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Nomura Asset Management Co Ltd | Institution | | Sold All | -495,000 | -100 % | | | | -1.06 % | $118,800 | | | | | | News Article | History of Nomura Asset Management Co Ltd Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Oshaughnessy Asset Management Llc | Institution | 135 | No Change | 0 | 0 % | $3,029 | $2,997 | $-32 | -1.06 % | $0 | | | | | | News Article | History of Oshaughnessy Asset Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 26,769 | Added More | 6,128 | 29.68 % | $600,696 | $594,272 | $-6,425 | -1.06 % | $-1,471 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 15,836 | Sold Some | -4,855 | -23.46 % | $355,360 | $351,559 | $-3,801 | -1.06 % | $1,165 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Principal Financial Group Inc | Institution | 958,242 | Added More | 826,163 | 625.50 % | $21,502,950 | $21,272,972 | $-229,978 | -1.06 % | $-198,279 | | | | | | News Article | History of Principal Financial Group Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Provident Trust Co | Institution | | Sold All | -6 | -100 % | | | | -1.06 % | $1 | | | | | | News Article | History of Provident Trust Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Provise Management Group Llc | Institution | 11,680 | No Change | 0 | 0 % | $262,099 | $259,296 | $-2,803 | -1.06 % | $0 | | | | | | News Article | History of Provise Management Group Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Royal Bank Of Scotland Group Plc | Institution | 61,706 | Added More | 36,543 | 145.22 % | $1,384,683 | $1,369,873 | $-14,809 | -1.06 % | $-8,770 | | | | | | News Article | History of Royal Bank Of Scotland Group Plc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Russell Frank Co | Institution | 363,509 | Sold Some | -151,620 | -29.43 % | $8,157,142 | $8,069,900 | $-87,242 | -1.06 % | $36,389 | | | | | | News Article | History of Russell Frank Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Schwartz Investment Counsel Inc | Institution | 12,000 | No Change | 0 | 0 % | $269,280 | $266,400 | $-2,880 | -1.06 % | $0 | | | | | | News Article | History of Schwartz Investment Counsel Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Sector Gamma Asa | No Data | 302,996 | No Compare | | | $6,799,230 | $6,726,511 | $-72,719 | -1.06 % | | | | | | | News Article | History of Sector Gamma Asa Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Security Global Investors Llc | Institution | 15,000 | New Holding | 15,000 | 100 % | $336,600 | $333,000 | $-3,600 | -1.06 % | $-3,600 | | | | | | News Article | History of Security Global Investors Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Security Management Co Llc | Institution | 19,300 | Added More | 6,600 | 51.96 % | $433,092 | $428,460 | $-4,632 | -1.06 % | $-1,584 | | | | | | News Article | History of Security Management Co Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Signaturefd Llc | No Data | | Sold All | -550 | -100 % | | | | -1.06 % | $132 | | | | | | News Article | History of Signaturefd Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Sm And R Investments Inc | Institution | 11,120 | Sold Some | -175 | -1.54 % | $249,533 | $246,864 | $-2,669 | -1.06 % | $42 | | | | | | News Article | History of Sm And R Investments Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Strategic Investment Management | Institution | 16,283 | Added More | 1,377 | 9.23 % | $365,391 | $361,483 | $-3,908 | -1.06 % | $-330 | | | | | | News Article | History of Strategic Investment Management Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Suntrust Banks Inc | Institution | 54,368 | Sold Some | -44,817 | -45.18 % | $1,220,018 | $1,206,970 | $-13,048 | -1.06 % | $10,756 | | | | | | News Article | History of Suntrust Banks Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | | Sold All | -41,014 | -100 % | | | | -1.06 % | $9,843 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Technical Financial Services Llc | Institution | 64,800 | New Holding | 64,800 | 100 % | $1,454,112 | $1,438,560 | $-15,552 | -1.06 % | $-15,552 | | | | | | News Article | History of Technical Financial Services Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Tewksbury Capital Management Ltd | Institution | | Sold All | -27,394 | -100 % | | | | -1.06 % | $6,575 | | | | | | News Article | History of Tewksbury Capital Management Ltd Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Ubs Oconnor Llc | Institution | | Sold All | -22,300 | -100 % | | | | -1.06 % | $5,352 | | | | | | News Article | History of Ubs Oconnor Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | United Services Automobile Association | Institution | 166,011 | Sold Some | -4,900 | -2.86 % | $3,725,287 | $3,685,444 | $-39,843 | -1.06 % | $1,176 | | | | | | News Article | History of United Services Automobile Association Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Virginia Retirement Systems Et Al | Institution | 216,173 | Added More | 161,700 | 296.84 % | $4,850,922 | $4,799,041 | $-51,882 | -1.06 % | $-38,808 | | | | | | News Article | History of Virginia Retirement Systems Et Al Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Westwood Management Corp | Institution | 16,900 | Sold Some | -302,200 | -94.70 % | $379,236 | $375,180 | $-4,056 | -1.06 % | $72,528 | | | | | | News Article | History of Westwood Management Corp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | World Asset Management Inc | Institution | 17,687 | Added More | 3,862 | 27.93 % | $396,896 | $392,651 | $-4,245 | -1.06 % | $-927 | | | | | | News Article | History of World Asset Management Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Zacks Investment Management | Institution | | Sold All | -18,207 | -100 % | | | | -1.06 % | $4,370 | | | | | | News Article | History of Zacks Investment Management Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-12 | 2009-08-31 | N-CSR | Satuit Capital Management Trust - Satuit Capital Small Cap Fund | No Data | 1,100 | New Holding | 1,100 | 100 % | $24,684 | $24,420 | $-264 | -1.06 % | $-264 | | | | | | News Article | History of Satuit Capital Management Trust - Satuit Capital Small Cap Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | American Century Companies Inc | Institution | 423,948 | Sold Some | -19,264 | -4.34 % | $9,772,001 | $9,411,646 | $-360,356 | -3.68 % | $16,374 | | | | | | News Article | History of American Century Companies Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Citigroup Inc | Institution | 561,366 | Added More | 138,579 | 32.77 % | $12,939,486 | $12,462,325 | $-477,161 | -3.68 % | $-117,792 | | | | | | News Article | History of Citigroup Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Clarivest Asset Management Llc | Institution | 385,400 | Added More | 264,200 | 217.98 % | $8,883,470 | $8,555,880 | $-327,590 | -3.68 % | $-224,570 | | | | | | News Article | History of Clarivest Asset Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Comerica Bank | Institution | 95,625 | Sold Some | -32,399 | -25.30 % | $2,204,156 | $2,122,875 | $-81,281 | -3.68 % | $27,539 | | | | | | News Article | History of Comerica Bank Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Dana Investment Advisors Inc | Institution | 1,102 | New Holding | 1,102 | 100 % | $25,401 | $24,464 | $-937 | -3.68 % | $-937 | | | | | | News Article | History of Dana Investment Advisors Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Glenmede Trust Co Na | Institution | 175,527 | Added More | 21,869 | 14.23 % | $4,045,897 | $3,896,699 | $-149,198 | -3.68 % | $-18,589 | | | | | | News Article | History of Glenmede Trust Co Na Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Highbridge Capital Management Llc | Institution | 795,287 | Sold Some | -61,556 | -7.18 % | $18,331,365 | $17,655,371 | $-675,994 | -3.68 % | $52,323 | | | | | | News Article | History of Highbridge Capital Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 1,215,207 | Added More | 690,143 | 131.43 % | $28,010,521 | $26,977,595 | $-1,032,926 | -3.68 % | $-586,622 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Paradigm Capital Management Inc | Institution | 662,700 | Sold Some | -158,640 | -19.31 % | $15,275,235 | $14,711,940 | $-563,295 | -3.68 % | $134,844 | | | | | | News Article | History of Paradigm Capital Management Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Royce And Associates Llc | Institution | 6,416,550 | Sold Some | -1,156,580 | -15.27 % | $147,901,478 | $142,447,410 | $-5,454,068 | -3.68 % | $983,093 | | | | | | News Article | History of Royce And Associates Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Sectoral Asset Management Inc | Institution | | Sold All | -904,551 | -100 % | | | | -3.68 % | $768,868 | | | | | | News Article | History of Sectoral Asset Management Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Tesseract Capital Llc | No Data | 200 | Sold Some | -8,541 | -97.71 % | $4,610 | $4,440 | $-170 | -3.68 % | $7,260 | | | | | | News Article | History of Tesseract Capital Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 241,776 | Added More | 65,291 | 36.99 % | $5,572,937 | $5,367,427 | $-205,510 | -3.68 % | $-55,497 | | | | | | News Article | History of Ubs Ag Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Bridgewater Associates Inc | Institution | 84,531 | Sold Some | -181,800 | -68.26 % | $1,960,274 | $1,876,588 | $-83,686 | -4.26 % | $179,982 | | | | | | News Article | History of Bridgewater Associates Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Ccm Partners | Institution | 16,513 | Sold Some | -987 | -5.64 % | $382,936 | $366,589 | $-16,348 | -4.26 % | $977 | | | | | | News Article | History of Ccm Partners Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Chartwell Investment Partners | Institution | 78,075 | Sold Some | -13,725 | -14.95 % | $1,810,559 | $1,733,265 | $-77,294 | -4.26 % | $13,588 | | | | | | News Article | History of Chartwell Investment Partners Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Federated Investors Inc | Institution | 56,337 | Sold Some | -21,807 | -27.90 % | $1,306,455 | $1,250,681 | $-55,774 | -4.26 % | $21,589 | | | | | | News Article | History of Federated Investors Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Gargoyle Services L L C | Institution | 90,049 | No Change | 0 | 0 % | $2,088,236 | $1,999,088 | $-89,149 | -4.26 % | $0 | | | | | | News Article | History of Gargoyle Services L L C Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | General Motors Investment Management Corp | Institution | | Sold All | -20,232 | -100 % | | | | -4.26 % | $20,030 | | | | | | News Article | History of General Motors Investment Management Corp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Intrepid Capital Management Inc | No Data | 17,085 | New Holding | 17,085 | 100 % | $396,201 | $379,287 | $-16,914 | -4.26 % | $-16,914 | | | | | | News Article | History of Intrepid Capital Management Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Johnson Investment Counsel Inc | Institution | 9,500 | New Holding | 9,500 | 100 % | $220,305 | $210,900 | $-9,405 | -4.26 % | $-9,405 | | | | | | News Article | History of Johnson Investment Counsel Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | New Amsterdam Partners Llc | Institution | 110,041 | No Change | 0 | 0 % | $2,551,851 | $2,442,910 | $-108,941 | -4.26 % | $0 | | | | | | News Article | History of New Amsterdam Partners Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Numeric Investors Llc | Institution | 114,792 | Sold Some | -184,705 | -61.67 % | $2,662,026 | $2,548,382 | $-113,644 | -4.26 % | $182,858 | | | | | | News Article | History of Numeric Investors Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | State Of Wisconsin Investment Board | Institution | 103,232 | Added More | 15,740 | 17.99 % | $2,393,950 | $2,291,750 | $-102,200 | -4.26 % | $-15,583 | | | | | | News Article | History of State Of Wisconsin Investment Board Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Vtl Associates Llc | Institution | | Sold All | -40 | -100 % | | | | -4.26 % | $40 | | | | | | News Article | History of Vtl Associates Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-09 | 2009-08-31 | N-CSR | American Performance Funds - Balanced Fund | Flexible Portfolio | 3,420 | Added More | 720 | 26.66 % | $79,310 | $75,924 | $-3,386 | -4.26 % | $-713 | | | | | | News Article | History of American Performance Funds - Balanced Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR/A | Baird Robert W And Co Inc | Institution | 25,232 | Added More | 1,490 | 6.27 % | $580,336 | $560,150 | $-20,186 | -3.47 % | $-1,192 | | | | | | News Article | History of Baird Robert W And Co Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Deere And Co | Institution | 35,731 | Sold Some | -11,154 | -23.79 % | $821,813 | $793,228 | $-28,585 | -3.47 % | $8,923 | | | | | | News Article | History of Deere And Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Hartford Investment Management Co | Institution | 22,666 | Sold Some | -60 | -0.26 % | $521,318 | $503,185 | $-18,133 | -3.47 % | $48 | | | | | | News Article | History of Hartford Investment Management Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 130,804 | Sold Some | -1,058 | -0.80 % | $3,008,492 | $2,903,849 | $-104,643 | -3.47 % | $846 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pioneer Investment Management Inc | Institution | | Sold All | -141,367 | -100 % | | | | -3.47 % | $113,094 | | | | | | News Article | History of Pioneer Investment Management Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | 221 | Sold Some | -136,876 | -99.83 % | $5,083 | $4,906 | $-177 | -3.47 % | $109,501 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Schwab Charles Investment Management Inc | Institution | 334,388 | Sold Some | -29,800 | -8.18 % | $7,690,924 | $7,423,414 | $-267,510 | -3.47 % | $23,840 | | | | | | News Article | History of Schwab Charles Investment Management Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 93,108 | Sold Some | -71,283 | -43.36 % | $2,141,484 | $2,066,998 | $-74,486 | -3.47 % | $57,026 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 1,395,813 | Added More | 16,793 | 1.21 % | $32,103,699 | $30,987,049 | $-1,116,650 | -3.47 % | $-13,434 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Unionbancal Corp | Institution | 52,800 | No Change | 0 | 0 % | $1,214,400 | $1,172,160 | $-42,240 | -3.47 % | $0 | | | | | | News Article | History of Unionbancal Corp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-06 | 2009-08-31 | N-CSR | Rbb Fund Inc - Senbanc Fund | Financial Services | 22,800 | New Holding | 22,800 | 100 % | $524,400 | $506,160 | $-18,240 | -3.47 % | $-18,240 | | | | | | News Article | History of Rbb Fund Inc - Senbanc Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Atlanta Life Investment Advisors Inc | Institution | 819,502 | Added More | 37,043 | 4.73 % | $18,758,401 | $18,192,944 | $-565,456 | -3.01 % | $-25,560 | | | | | | News Article | History of Atlanta Life Investment Advisors Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Bank Of Hawaii | Institution | 4,100 | Sold Some | -300 | -6.81 % | $93,849 | $91,020 | $-2,829 | -3.01 % | $207 | | | | | | News Article | History of Bank Of Hawaii Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Fixed Income Securities Lp | Institution | 5,600 | Added More | 600 | 12.00 % | $128,184 | $124,320 | $-3,864 | -3.01 % | $-414 | | | | | | News Article | History of Fixed Income Securities Lp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Nisa Investment Advisors L L C | Institution | 38,040 | No Change | 0 | 0 % | $870,736 | $844,488 | $-26,248 | -3.01 % | $0 | | | | | | News Article | History of Nisa Investment Advisors L L C Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Parametric Portfolio Associates | Institution | 149,803 | Added More | 35,824 | 31.43 % | $3,428,991 | $3,325,627 | $-103,364 | -3.01 % | $-24,719 | | | | | | News Article | History of Parametric Portfolio Associates Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Profund Advisors Llc | Institution | 26,858 | Added More | 3,198 | 13.51 % | $614,780 | $596,248 | $-18,532 | -3.01 % | $-2,207 | | | | | | News Article | History of Profund Advisors Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Proshare Advisors Llc | Institution | 16,873 | Sold Some | -9,421 | -35.82 % | $386,223 | $374,581 | $-11,642 | -3.01 % | $6,500 | | | | | | News Article | History of Proshare Advisors Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Teacher Retirement System Of Texas | Institution | 41,750 | Sold Some | -129,534 | -75.62 % | $955,658 | $926,850 | $-28,808 | -3.01 % | $89,378 | | | | | | News Article | History of Teacher Retirement System Of Texas Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Babson Capital Management Llc | Institution | 23,100 | Added More | 9,000 | 63.82 % | $519,750 | $512,820 | $-6,930 | -1.33 % | $-2,700 | | | | | | News Article | History of Babson Capital Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Capital One National Association | Institution | | Sold All | -10,145 | -100 % | | | | -1.33 % | $3,044 | | | | | | News Article | History of Capital One National Association Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Curian Capital Llc | Institution | 14,780 | Sold Some | -21,213 | -58.93 % | $332,550 | $328,116 | $-4,434 | -1.33 % | $6,364 | | | | | | News Article | History of Curian Capital Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Geewax Plus Partners Llc | Institution | 8,513 | Added More | 8,113 | 2028.25 % | $191,543 | $188,989 | $-2,554 | -1.33 % | $-2,434 | | | | | | News Article | History of Geewax Plus Partners Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Gw Capital Management Incco | Institution | 77,755 | Added More | 1,992 | 2.62 % | $1,749,488 | $1,726,161 | $-23,327 | -1.33 % | $-598 | | | | | | News Article | History of Gw Capital Management Incco Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Tradeworx Inc | Institution | 15,223 | New Holding | 15,223 | 100 % | $342,518 | $337,951 | $-4,567 | -1.33 % | $-4,567 | | | | | | News Article | History of Tradeworx Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-04 | 2009-08-31 | N-CSRS | Gmo Trust - Gmo Value Fund | Multi-Cap Value | | Sold All | -12,800 | -100 % | | | | -1.33 % | $3,840 | | | | | | News Article | History of Gmo Trust - Gmo Value Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | King Luther Capital Management Corp | Institution | 709,270 | Added More | 19,280 | 2.79 % | $15,994,039 | $15,745,794 | $-248,245 | -1.55 % | $-6,748 | | | | | | News Article | History of King Luther Capital Management Corp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Prudential Financial Inc | Institution | 423,030 | Sold Some | -671,075 | -61.33 % | $9,539,327 | $9,391,266 | $-148,061 | -1.55 % | $234,876 | | | | | | News Article | History of Prudential Financial Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-03 | 2009-08-31 | N-CSR | California Investment Trust - S And P Midcap Index Fund | Mid-Cap Core | 16,513 | Sold Some | -987 | -5.64 % | $372,368 | $366,589 | $-5,780 | -1.55 % | $345 | | | | | | News Article | History of California Investment Trust - S And P Midcap Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR/A | Advanced Investment Partners Llc | No Data | 36,296 | New Holding | 36,296 | 100 % | $815,571 | $805,771 | $-9,800 | -1.20 % | $-9,800 | | | | | | News Article | History of Advanced Investment Partners Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Citizens Bank Wealth Management Na | Institution | 4,092 | Added More | 2,772 | 210.00 % | $91,947 | $90,842 | $-1,105 | -1.20 % | $-748 | | | | | | News Article | History of Citizens Bank Wealth Management Na Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Ghp Investment Advisors Inc | Institution | 1,200 | No Change | 0 | 0 % | $26,964 | $26,640 | $-324 | -1.20 % | $0 | | | | | | News Article | History of Ghp Investment Advisors Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Golden Capital Management Llc | Institution | 396,885 | Added More | 17,700 | 4.66 % | $8,918,006 | $8,810,847 | $-107,159 | -1.20 % | $-4,779 | | | | | | News Article | History of Golden Capital Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Thrivent Financial For Lutherans | Institution | 11,400 | Sold Some | -12,400 | -52.10 % | $256,158 | $253,080 | $-3,078 | -1.20 % | $3,348 | | | | | | News Article | History of Thrivent Financial For Lutherans Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-30 | 2009-09-30 | N-Q | Forum Funds - Shaker Fund | Specialty & Misc | 90,945 | New Holding | 90,945 | 100 % | $2,037,168 | $2,018,979 | $-18,189 | -0.89 % | $-18,189 | | | | | | News Article | History of Forum Funds - Shaker Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Opus Capital Group Llc | Institution | 626,002 | Added More | 34,724 | 5.87 % | $14,022,445 | $13,897,244 | $-125,200 | -0.89 % | $-6,945 | | | | | | News Article | History of Opus Capital Group Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Robeco Investment Management Inc | Institution | 27,901 | Added More | 5,044 | 22.06 % | $624,982 | $619,402 | $-5,580 | -0.89 % | $-1,009 | | | | | | News Article | History of Robeco Investment Management Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Texas Permanent School Fund | Institution | 188,223 | Sold Some | -1,896 | -0.99 % | $4,216,195 | $4,178,551 | $-37,645 | -0.89 % | $379 | | | | | | News Article | History of Texas Permanent School Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-30 | 2009-08-31 | N-CSRS | Fidelity Commonwealth Trust Ii - Fidelity Mid Cap Enhanced Index Fund | Mid-Cap Core | 4,270 | Added More | 1,570 | 58.14 % | $95,648 | $94,794 | $-854 | -0.89 % | $-314 | | | | | | News Article | History of Fidelity Commonwealth Trust Ii - Fidelity Mid Cap Enhanced Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-30 | 2009-08-31 | N-CSR | Growth Fund Of America Inc - Growth Fund Of America Inc | Multi-Cap Growth | | Sold All | -175,200 | -100 % | | | | -0.89 % | $35,040 | | | | | | News Article | History of Growth Fund Of America Inc - Growth Fund Of America Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-30 | 2009-08-31 | N-CSR | Vanguard World Fund - Vanguard Health Care Index Fund | Health/Biotech | | Sold All | -54,705 | -100 % | | | | -0.89 % | $10,941 | | | | | | News Article | History of Vanguard World Fund - Vanguard Health Care Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 236,215 | Added More | 36,230 | 18.11 % | $5,236,887 | $5,243,973 | $7,086 | 0.13 % | $1,087 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Greenwich Wealth Management Llc | Institution | 300,000 | No Change | 0 | 0 % | $6,651,000 | $6,660,000 | $9,000 | 0.13 % | $0 | | | | | | News Article | History of Greenwich Wealth Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | John G Ullman And Associates Inc | Institution | 57,000 | Sold Some | -1,000 | -1.72 % | $1,263,690 | $1,265,400 | $1,710 | 0.13 % | $-30 | | | | | | News Article | History of John G Ullman And Associates Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Seizert Capital Partners Llc | Institution | 248,013 | Added More | 18,450 | 8.03 % | $5,498,448 | $5,505,889 | $7,440 | 0.13 % | $554 | | | | | | News Article | History of Seizert Capital Partners Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Smith Graham Co Investment Advisors Lp | No Data | 196,598 | No Compare | | | $4,358,578 | $4,364,476 | $5,898 | 0.13 % | | | | | | | News Article | History of Smith Graham Co Investment Advisors Lp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Evergreen Equity Trust De - Evergreen Market Index Fund | Specialty & Misc | | Sold All | -1,068 | -100 % | | | | 0.13 % | $-32 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Market Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Evergreen Equity Trust De - Evergreen Market Index Growth Fund | Multi-Cap Growth | | Sold All | -10,782 | -100 % | | | | 0.13 % | $-323 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Market Index Growth Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Evergreen Equity Trust De - Evergreen Market Index Value Fund | Multi-Cap Value | 10,633 | Added More | 9,576 | 905.96 % | $235,734 | $236,053 | $319 | 0.13 % | $287 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Market Index Value Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Cornerstone Strategy Fund | Specialty & Misc | | Sold All | -89,783 | -100 % | | | | 0.13 % | $-2,693 | | | | | | News Article | History of Usaa Mutual Funds Trust - Cornerstone Strategy Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | | Sold All | -1,028 | -100 % | | | | 0.13 % | $-31 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | | Sold All | -108,000 | -100 % | | | | 0.13 % | $-3,240 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Kalmar Investments Inc | Institution | | Sold All | -1,230,520 | -100 % | | | | 1.18 % | $-319,935 | | | | | | News Article | History of Kalmar Investments Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-28 | 2009-08-31 | N-Q | Alliancebernstein Balanced Shares Inc - Alliancebernstein Balanced Shares Inc | Flexible Portfolio | 90,990 | Sold Some | -23,600 | -20.59 % | $1,996,321 | $2,019,978 | $23,657 | 1.18 % | $-6,136 | | | | | | News Article | History of Alliancebernstein Balanced Shares Inc - Alliancebernstein Balanced Shares Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-28 | 2009-08-31 | N-Q | Alliancebernstein Focused Growth And Income Fund Inc - Alliancebernstein Focused Growth And Income Fund Inc | Multi-Cap Growth | 103,300 | No Change | 0 | 0 % | $2,266,402 | $2,293,260 | $26,858 | 1.18 % | $0 | | | | | | News Article | History of Alliancebernstein Focused Growth And Income Fund Inc - Alliancebernstein Focused Growth And Income Fund Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-28 | 2009-08-31 | N-Q | American Century Strategic Asset Allocations Inc - Newton Fund | Small-Cap Core | 30,288 | Added More | 3,023 | 11.08 % | $664,519 | $672,394 | $7,875 | 1.18 % | $786 | | | | | | News Article | History of American Century Strategic Asset Allocations Inc - Newton Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Dupont Capital Management | Institution | 58,300 | Sold Some | -3,000 | -4.89 % | $1,330,406 | $1,294,260 | $-36,146 | -2.71 % | $1,860 | | | | | | News Article | History of Dupont Capital Management Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Rivanna Capital Llc | Institution | 301,657 | Added More | 114,094 | 60.82 % | $6,883,813 | $6,696,785 | $-187,027 | -2.71 % | $-70,738 | | | | | | News Article | History of Rivanna Capital Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Eveans Bash Magrino And Klein Inc | Institution | 95,380 | Sold Some | -1,105 | -1.14 % | $2,193,740 | $2,117,436 | $-76,304 | -3.47 % | $884 | | | | | | News Article | History of Eveans Bash Magrino And Klein Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Schroder Investment Management Group | Institution | 373,379 | Sold Some | -269,690 | -41.93 % | $8,587,717 | $8,289,014 | $-298,703 | -3.47 % | $215,752 | | | | | | News Article | History of Schroder Investment Management Group Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Smith Asset Management Group Lp | Institution | 87,600 | No Change | 0 | 0 % | $2,014,800 | $1,944,720 | $-70,080 | -3.47 % | $0 | | | | | | News Article | History of Smith Asset Management Group Lp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Trillium Asset Management Corp | Institution | 91,853 | Added More | 7,804 | 9.28 % | $2,112,619 | $2,039,137 | $-73,482 | -3.47 % | $-6,243 | | | | | | News Article | History of Trillium Asset Management Corp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf | Specialty & Misc | 60 | No Change | 0 | 0 % | $1,380 | $1,332 | $-48 | -3.47 % | $0 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 286,133 | Added More | 157,004 | 121.58 % | $6,581,059 | $6,352,153 | $-228,906 | -3.47 % | $-125,603 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Cambridge Investment Research Advisors Inc | Institution | 13,736 | New Holding | 13,736 | 100 % | $319,637 | $304,939 | $-14,698 | -4.59 % | $-14,698 | | | | | | News Article | History of Cambridge Investment Research Advisors Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Advisors Llc | Institution | 972,775 | Added More | 7,875 | 0.81 % | $22,860,213 | $21,595,605 | $-1,264,608 | -5.53 % | $-10,238 | | | | | | News Article | History of Blackrock Advisors Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Group Ltd | Institution | 116,297 | Sold Some | -26,600 | -18.61 % | $2,732,980 | $2,581,793 | $-151,186 | -5.53 % | $34,580 | | | | | | News Article | History of Blackrock Group Ltd Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | 578,238 | Added More | 296,716 | 105.39 % | $13,588,593 | $12,836,884 | $-751,709 | -5.53 % | $-385,731 | | | | | | News Article | History of Blackrock Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 3,049,032 | Added More | 630,995 | 26.09 % | $71,652,252 | $67,688,510 | $-3,963,742 | -5.53 % | $-820,294 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Riverfront Investment Group Llc | No Data | 158,514 | Added More | 28,765 | 22.16 % | $3,725,079 | $3,519,011 | $-206,068 | -5.53 % | $-37,395 | | | | | | News Article | History of Riverfront Investment Group Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | S And T Bank | Institution | 252 | Sold Some | -962 | -79.24 % | $5,922 | $5,594 | $-328 | -5.53 % | $1,251 | | | | | | News Article | History of S And T Bank Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Temujin Fund Management Llc | Institution | | Sold All | -24,800 | -100 % | | | | -5.53 % | $32,240 | | | | | | News Article | History of Temujin Fund Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 2,859,688 | Sold Some | -43,660 | -1.50 % | $66,287,568 | $63,485,074 | $-2,802,494 | -4.22 % | $42,787 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 367,295 | Added More | 43,281 | 13.35 % | $8,513,898 | $8,153,949 | $-359,949 | -4.22 % | $-42,415 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Tiedemann Trust Co | Institution | 9,286 | New Holding | 9,286 | 100 % | $215,249 | $206,149 | $-9,100 | -4.22 % | $-9,100 | | | | | | News Article | History of Tiedemann Trust Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Public Employees Retirement Association Of Colorado | Institution | 223,090 | No Change | 0 | 0 % | $5,238,153 | $4,952,598 | $-285,555 | -5.45 % | $0 | | | | | | News Article | History of Public Employees Retirement Association Of Colorado Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Teachers Retirement System Of The State Of Kentucky | Institution | 49,800 | No Change | 0 | 0 % | $1,169,304 | $1,105,560 | $-63,744 | -5.45 % | $0 | | | | | | News Article | History of Teachers Retirement System Of The State Of Kentucky Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Shenandoah Asset Management Llc | Institution | 78,314 | Sold Some | -3,170 | -3.89 % | $1,857,608 | $1,738,571 | $-119,037 | -6.40 % | $4,818 | | | | | | News Article | History of Shenandoah Asset Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Strs Ohio | Institution | 259,700 | Added More | 9,093 | 3.62 % | $6,160,084 | $5,765,340 | $-394,744 | -6.40 % | $-13,821 | | | | | | News Article | History of Strs Ohio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Capstone Asset Management Co | Institution | 10,330 | Added More | 100 | 0.97 % | $242,445 | $229,326 | $-13,119 | -5.41 % | $-127 | | | | | | News Article | History of Capstone Asset Management Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Cullen Frost Bankers Inc | Institution | 12,330 | New Holding | 12,330 | 100 % | $289,385 | $273,726 | $-15,659 | -5.41 % | $-15,659 | | | | | | News Article | History of Cullen Frost Bankers Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-16 | 2009-09-30 | 13F-HR | First Horizon National Corp | Institution | 5,000 | No Change | 0 | 0 % | $117,350 | $111,000 | $-6,350 | -5.41 % | $0 | | | | | | News Article | History of First Horizon National Corp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Trust Co Of Vermont | Institution | 400 | No Change | 0 | 0 % | $9,388 | $8,880 | $-508 | -5.41 % | $0 | | | | | | News Article | History of Trust Co Of Vermont Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Wright Investors Service Inc | Institution | 16,283 | Sold Some | -10,233 | -38.59 % | $382,162 | $361,483 | $-20,679 | -5.41 % | $12,996 | | | | | | News Article | History of Wright Investors Service Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Harris Financial Corp | Institution | 266,076 | Sold Some | -40,352 | -13.16 % | $6,348,573 | $5,906,887 | $-441,686 | -6.95 % | $66,984 | | | | | | News Article | History of Harris Financial Corp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | New England Asset Management Llc | Institution | 98 | Sold Some | -3,852 | -97.51 % | $2,338 | $2,176 | $-163 | -6.95 % | $6,394 | | | | | | News Article | History of New England Asset Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 252,142 | Sold Some | -162,197 | -39.14 % | $6,016,108 | $5,597,552 | $-418,556 | -6.95 % | $269,247 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-15 | 2007-03-31 | 13F-HR/A | Northwestern Mutual Life Insurance Co | Institution | | Sold All | -88 | -100 % | | | | -6.95 % | $146 | | | | | | News Article | History of Northwestern Mutual Life Insurance Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Alpha Windward Llc | Institution | 10,948 | New Holding | 10,948 | 100 % | $261,438 | $243,046 | $-18,393 | -7.03 % | $-18,393 | | | | | | News Article | History of Alpha Windward Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-14 | 2009-09-30 | 13F-HR | First Citizens Bank And Trust Co | Institution | 15,091 | Sold Some | -649 | -4.12 % | $360,373 | $335,020 | $-25,353 | -7.03 % | $1,090 | | | | | | News Article | History of First Citizens Bank And Trust Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-13 | 2009-09-30 | 13F-HR | Financial Architects Inc | Institution | 1,000 | No Change | 0 | 0 % | $23,830 | $22,200 | $-1,630 | -6.84 % | $0 | | | | | | News Article | History of Financial Architects Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-13 | 2009-09-30 | 13F-HR | First Merchants Corp | Institution | 35,265 | Sold Some | -1,030 | -2.83 % | $840,365 | $782,883 | $-57,482 | -6.84 % | $1,679 | | | | | | News Article | History of First Merchants Corp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-13 | 2009-09-30 | 13F-HR | Harold C Brown And Co Llc | Institution | 41,140 | No Change | 0 | 0 % | $980,366 | $913,308 | $-67,058 | -6.84 % | $0 | | | | | | News Article | History of Harold C Brown And Co Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-13 | 2009-09-30 | 13F-HR | Tealwood Asset Management Inc | Institution | 124,535 | Added More | 1,130 | 0.91 % | $2,967,669 | $2,764,677 | $-202,992 | -6.84 % | $-1,842 | | | | | | News Article | History of Tealwood Asset Management Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-09 | 2009-07-31 | N-CSR | First Trust Exchange-Traded Alphadex Fund - First Trust Health Care Alphadex Fund | Health/Biotech | 18,506 | Added More | 7,458 | 67.50 % | $440,813 | $410,833 | $-29,980 | -6.80 % | $-12,082 | | | | | | News Article | History of First Trust Exchange-Traded Alphadex Fund - First Trust Health Care Alphadex Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 193,573 | Sold Some | -1,014 | -0.52 % | $4,636,073 | $4,297,321 | $-338,753 | -7.30 % | $1,775 | | | | | | News Article | History of Rhumbline Advisers Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-08 | 2008-07-31 | N-CSR | Morgan Stanley Health Sciences Trust - None | Specialty & Misc | 1,967 | Sold Some | -159,633 | -98.78 % | $47,110 | $43,667 | $-3,442 | -7.30 % | $279,358 | | | | | | News Article | History of Morgan Stanley Health Sciences Trust - None Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-05 | 2009-09-30 | 13F-HR | Natcan Investment Management Inc | Institution | 23,400 | New Holding | 23,400 | 100 % | $547,560 | $519,480 | $-28,080 | -5.12 % | $-28,080 | | | | | | News Article | History of Natcan Investment Management Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Pacific Capital Funds - Value Fund | Multi-Cap Core | 3,500 | No Change | 0 | 0 % | $77,385 | $77,700 | $315 | 0.40 % | $0 | | | | | | News Article | History of Pacific Capital Funds - Value Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | 108,000 | New Holding | 108,000 | 100 % | $2,387,880 | $2,397,600 | $9,720 | 0.40 % | $9,720 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | 1,028 | New Holding | 1,028 | 100 % | $22,729 | $22,822 | $93 | 0.40 % | $93 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Income Stock Fund | Equity Income | | Sold All | -2,200 | -100 % | | | | 0.40 % | $-198 | | | | | | News Article | History of Usaa Mutual Funds Trust - Income Stock Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-29 | 2009-07-31 | N-Q | American Century Mutual Funds Inc - Balanced Fund | Mixed-Asset Target Allocation Growth | 18,837 | Added More | 906 | 5.05 % | $429,860 | $418,181 | $-11,679 | -2.71 % | $-562 | | | | | | News Article | History of American Century Mutual Funds Inc - Balanced Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 149,945 | Added More | 13,277 | 9.71 % | $3,421,745 | $3,328,779 | $-92,966 | -2.71 % | $-8,232 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio | No Data | 3,100 | No Change | 0 | 0 % | $70,742 | $68,820 | $-1,922 | -2.71 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio | No Data | 1,900 | No Change | 0 | 0 % | $43,358 | $42,180 | $-1,178 | -2.71 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Eclipse Funds - Mainstay Balanced Fund | Mixed-Asset Target Allocation Growth | 15,974 | New Holding | 15,974 | 100 % | $364,527 | $354,623 | $-9,904 | -2.71 % | $-9,904 | | | | | | News Article | History of Eclipse Funds - Mainstay Balanced Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Beacon Street Trust - Fidelity Tax Managed Stock Fund | Specialty & Misc | 31,800 | New Holding | 31,800 | 100 % | $725,676 | $705,960 | $-19,716 | -2.71 % | $-19,716 | | | | | | News Article | History of Fidelity Beacon Street Trust - Fidelity Tax Managed Stock Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Ishares Trust - Ishares Kld 400 Social Index Fund | Specialty & Misc | 1,998 | Added More | 158 | 8.58 % | $45,594 | $44,356 | $-1,239 | -2.71 % | $-98 | | | | | | News Article | History of Ishares Trust - Ishares Kld 400 Social Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Ishares Trust - Ishares Morningstar Mid Core Index Fund | Mid-Cap Core | 12,997 | New Holding | 12,997 | 100 % | $296,592 | $288,533 | $-8,058 | -2.71 % | $-8,058 | | | | | | News Article | History of Ishares Trust - Ishares Morningstar Mid Core Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Ishares Trust - Ishares Morningstar Mid Growth Index Fund | Mid-Cap Growth | | Sold All | -39,176 | -100 % | | | | -2.71 % | $24,289 | | | | | | News Article | History of Ishares Trust - Ishares Morningstar Mid Growth Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Janus Investment Fund - Janus Mid Cap Value Fund | Mid-Cap Value | | Sold All | -1,200,000 | -100 % | | | | -2.71 % | $744,000 | | | | | | News Article | History of Janus Investment Fund - Janus Mid Cap Value Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Janus Investment Fund - Janus Worldwide Fund | Global Large-Cap Growth | 1,475,000 | Added More | 275,000 | 22.91 % | $33,659,500 | $32,745,000 | $-914,500 | -2.71 % | $-170,500 | | | | | | News Article | History of Janus Investment Fund - Janus Worldwide Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Jnl Investors Series Trust - Jackson Perspective Index 5 Fund | Specialty & Misc | 1,322 | No Change | 0 | 0 % | $30,168 | $29,348 | $-820 | -2.71 % | $0 | | | | | | News Article | History of Jnl Investors Series Trust - Jackson Perspective Index 5 Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Mainstay Funds - Mainstay Common Stock Fund | Large-Cap Core | | Sold All | -21,999 | -100 % | | | | -2.71 % | $13,639 | | | | | | News Article | History of Mainstay Funds - Mainstay Common Stock Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Northern Lights Fund Trust - Kcm Macro Trends Fund | No Data | 25,300 | No Change | 0 | 0 % | $577,346 | $561,660 | $-15,686 | -2.71 % | $0 | | | | | | News Article | History of Northern Lights Fund Trust - Kcm Macro Trends Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Russell Investment Co - International Fund | International Multi-Cap Core | 143,202 | Sold Some | -2,246 | -1.54 % | $3,267,870 | $3,179,084 | $-88,785 | -2.71 % | $1,393 | | | | | | News Article | History of Russell Investment Co - International Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Vanguard Explorer Fund - Vanguard Explorer Fund | Small-Cap Growth | 968,550 | Sold Some | -626,590 | -39.28 % | $22,102,311 | $21,501,810 | $-600,501 | -2.71 % | $388,486 | | | | | | News Article | History of Vanguard Explorer Fund - Vanguard Explorer Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Alliancebernstein Growth And Income Fund Inc - Alliancebernstein Growth And Income Fund Inc | Multi-Cap Growth | 334,075 | Sold Some | -5,625 | -1.65 % | $7,606,888 | $7,416,465 | $-190,423 | -2.50 % | $3,206 | | | | | | News Article | History of Alliancebernstein Growth And Income Fund Inc - Alliancebernstein Growth And Income Fund Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Dryden Small Cap Core Equity Fund Inc - Dryden Small Cap Core Equity Fund Inc | Small-Cap Core | 9,900 | New Holding | 9,900 | 100 % | $225,423 | $219,780 | $-5,643 | -2.50 % | $-5,643 | | | | | | News Article | History of Dryden Small Cap Core Equity Fund Inc - Dryden Small Cap Core Equity Fund Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Franklin Value Investors Trust - Franklin Large Cap Value Fund | Large-Cap Value | | Sold All | -41,600 | -100 % | | | | -2.50 % | $23,712 | | | | | | News Article | History of Franklin Value Investors Trust - Franklin Large Cap Value Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Harbor Funds - Harbor Mid Cap Value Fund | Mid-Cap Value | 16,300 | No Change | 0 | 0 % | $371,151 | $361,860 | $-9,291 | -2.50 % | $0 | | | | | | News Article | History of Harbor Funds - Harbor Mid Cap Value Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Enhanced Index Growth Fund | Large-Cap Core | | Sold All | -8,700 | -100 % | | | | -2.50 % | $4,959 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Enhanced Index Growth Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Enhanced Index Value Fund | Multi-Cap Value | 12,100 | No Change | 0 | 0 % | $275,517 | $268,620 | $-6,897 | -2.50 % | $0 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Enhanced Index Value Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Main Street Fund | Small-Cap Core | | Sold All | -4,800 | -100 % | | | | -2.50 % | $2,736 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Main Street Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund | Small-Cap Core | 4,031 | Added More | 601 | 17.52 % | $91,786 | $89,488 | $-2,298 | -2.50 % | $-343 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund | Small-Cap Core | 8,218 | Added More | 1,918 | 30.44 % | $187,124 | $182,440 | $-4,684 | -2.50 % | $-1,093 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Old Westbury Funds Inc - International Fund | International Multi-Cap Core | 2,600 | New Holding | 2,600 | 100 % | $59,202 | $57,720 | $-1,482 | -2.50 % | $-1,482 | | | | | | News Article | History of Old Westbury Funds Inc - International Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust - Powershares Dynamic Healthcare Sector Portfolio | Health/Biotech | | Sold All | -42,995 | -100 % | | | | -2.50 % | $24,507 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust - Powershares Dynamic Healthcare Sector Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust - Powershares Dynamic Mid Cap Growth Portfolio | Mid-Cap Growth | | Sold All | -34,511 | -100 % | | | | -2.50 % | $19,671 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust - Powershares Dynamic Mid Cap Growth Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Schwab Capital Trust - Schwab Core Equity Fund | Multi-Cap Core | | Sold All | -86,560 | -100 % | | | | -2.50 % | $49,339 | | | | | | News Article | History of Schwab Capital Trust - Schwab Core Equity Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Schwab Capital Trust - Schwab Fundamental Us Large Company Index Fund | Large-Cap Core | 2,300 | New Holding | 2,300 | 100 % | $52,371 | $51,060 | $-1,311 | -2.50 % | $-1,311 | | | | | | News Article | History of Schwab Capital Trust - Schwab Fundamental Us Large Company Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Schwab Capital Trust - Schwab Health Care Fund | Health/Biotech | 175,000 | No Change | 0 | 0 % | $3,984,750 | $3,885,000 | $-99,750 | -2.50 % | $0 | | | | | | News Article | History of Schwab Capital Trust - Schwab Health Care Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Schwab Capital Trust - Schwab Large Cap Growth Fund | Large-Cap Growth | 35,000 | No Change | 0 | 0 % | $796,950 | $777,000 | $-19,950 | -2.50 % | $0 | | | | | | News Article | History of Schwab Capital Trust - Schwab Large Cap Growth Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-25 | 2009-06-30 | 13F-HR/A | Kbc Group Nv | Institution | 119,178 | Added More | 106,081 | 809.96 % | $2,638,601 | $2,645,752 | $7,151 | 0.27 % | $6,365 | | | | | | News Article | History of Kbc Group Nv Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-24 | 2009-07-31 | N-Q | Nationwide Mutual Funds - Nationwide Mid Cap Market Index Fund | Mid-Cap Core | | Sold All | -102,900 | -100 % | | | | -1.59 % | $37,044 | | | | | | News Article | History of Nationwide Mutual Funds - Nationwide Mid Cap Market Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-21 | 2009-06-30 | 13F-HR/A | Eaton Vance Management | Institution | 20,952 | New Holding | 20,952 | 100 % | $472,468 | $465,134 | $-7,333 | -1.55 % | $-7,333 | | | | | | News Article | History of Eaton Vance Management Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust - S And P Midcap 400 Pure Growth Etf | Mid-Cap Growth | 10,317 | New Holding | 10,317 | 100 % | $234,505 | $229,037 | $-5,468 | -2.33 % | $-5,468 | | | | | | News Article | History of Rydex Etf Trust - S And P Midcap 400 Pure Growth Etf Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-16 | 2009-06-30 | N-Q | Forum Funds - Fountainhead Special Value Fund | Multi-Cap Value | 13,500 | New Holding | 13,500 | 100 % | $309,825 | $299,700 | $-10,125 | -3.26 % | $-10,125 | | | | | | News Article | History of Forum Funds - Fountainhead Special Value Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-15 | 2009-03-31 | 13F-HR/A | Highbridge Capital Management Llc | Institution | 680,425 | Added More | 638,622 | 1527.69 % | $15,663,384 | $15,105,435 | $-557,949 | -3.56 % | $-523,670 | | | | | | News Article | History of Highbridge Capital Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 6,593,944 | Added More | 1,087,436 | 19.74 % | $151,331,015 | $146,385,557 | $-4,945,458 | -3.26 % | $-815,577 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 6,330,074 | Added More | 823,566 | 14.95 % | $145,275,198 | $140,527,643 | $-4,747,556 | -3.26 % | $-617,675 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-10 | 2009-06-30 | 13F-HR/A | Perkins Investment Management Llc | No Data | 1,714,373 | Added More | 6,053 | 0.35 % | $39,293,429 | $38,059,081 | $-1,234,349 | -3.14 % | $-4,358 | | | | | | News Article | History of Perkins Investment Management Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-09 | 2009-06-30 | N-CSRS | Value Line Centurion Fund Inc - Value Line Centurion Fund Inc | Multi-Cap Value | | Sold All | -63,000 | -100 % | | | | -2.46 % | $35,280 | | | | | | News Article | History of Value Line Centurion Fund Inc - Value Line Centurion Fund Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-09 | 2009-06-30 | N-CSRS | Value Line Fund Inc - Value Line Fund Inc | Multi-Cap Growth | | Sold All | -39,000 | -100 % | | | | -2.46 % | $21,840 | | | | | | News Article | History of Value Line Fund Inc - Value Line Fund Inc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Allianz Variable Insurance Products Trust - Azl Mid Cap Index Fund | No Data | 4,553 | No Compare | | | $102,898 | $101,077 | $-1,821 | -1.76 % | | | | | | | News Article | History of Allianz Variable Insurance Products Trust - Azl Mid Cap Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Baird Funds Inc - Riverfront Long-Term Growth Fund | No Data | 5,648 | Added More | 1,449 | 34.50 % | $127,645 | $125,386 | $-2,259 | -1.76 % | $-580 | | | | | | News Article | History of Baird Funds Inc - Riverfront Long-Term Growth Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Calvert Variable Series Inc - Ameritas Mid Cap Growth Portfolio | Mid-Cap Growth | 28,500 | New Holding | 28,500 | 100 % | $644,100 | $632,700 | $-11,400 | -1.76 % | $-11,400 | | | | | | News Article | History of Calvert Variable Series Inc - Ameritas Mid Cap Growth Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Master Investment Portfolio - Active Stock Portfolio | Specialty & Misc | 8,085 | New Holding | 8,085 | 100 % | $182,721 | $179,487 | $-3,234 | -1.76 % | $-3,234 | | | | | | News Article | History of Master Investment Portfolio - Active Stock Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-08 | 2009-06-30 | N-CSR | Nuveen Investment Trust - Nuveen Enhanced Mid-Cap Fund | No Data | | Sold All | -90 | -100 % | | | | -1.76 % | $36 | | | | | | News Article | History of Nuveen Investment Trust - Nuveen Enhanced Mid-Cap Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-08 | 2009-06-30 | N-CSR | Revenueshares Etf Trust - Revenueshares Mid Cap Fund | Mid-Cap Core | 1,149 | Added More | 576 | 100.52 % | $25,967 | $25,508 | $-460 | -1.76 % | $-230 | | | | | | News Article | History of Revenueshares Etf Trust - Revenueshares Mid Cap Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds - Banking Fund | Financial Services | 20,691 | Added More | 13,460 | 186.14 % | $467,617 | $459,340 | $-8,276 | -1.76 % | $-5,384 | | | | | | News Article | History of Rydex Series Funds - Banking Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Biotechnology Fund | Health/Biotech | 8,450 | Added More | 3,070 | 57.06 % | $190,970 | $187,590 | $-3,380 | -1.76 % | $-1,228 | | | | | | News Article | History of Rydex Variable Trust - Biotechnology Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Summit Mutual Funds Inc - Zenith Portfolio | Specialty & Misc | 14,415 | Sold Some | -59 | -0.40 % | $325,779 | $320,013 | $-5,766 | -1.76 % | $24 | | | | | | News Article | History of Summit Mutual Funds Inc - Zenith Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Advanced Series Trust - Ast First Trust Capital Appreciation Target Portfolio | Specialty & Misc | | Sold All | -235,088 | -100 % | | | | -1.06 % | $56,421 | | | | | | News Article | History of Advanced Series Trust - Ast First Trust Capital Appreciation Target Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Advanced Series Trust - Ast Pimco Total Return Bond Portfolio | Specialty & Misc | | Sold All | -17,700 | -100 % | | | | -1.06 % | $4,248 | | | | | | News Article | History of Advanced Series Trust - Ast Pimco Total Return Bond Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | American Funds Insurance Series - Growth Fund | Multi-Cap Growth | | Sold All | -994,151 | -100 % | | | | -1.06 % | $238,596 | | | | | | News Article | History of American Funds Insurance Series - Growth Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio | Small-Cap Growth | | Sold All | -29,000 | -100 % | | | | -1.06 % | $6,960 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Value Portfolio | Small-Cap Value | 17,000 | Sold Some | -8,660 | -33.74 % | $381,480 | $377,400 | $-4,080 | -1.06 % | $2,078 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Value Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Blackrock Series Fund Inc - Blackrock Balanced Capital Portfolio | Flexible Portfolio | 144,000 | New Holding | 144,000 | 100 % | $3,231,360 | $3,196,800 | $-34,560 | -1.06 % | $-34,560 | | | | | | News Article | History of Blackrock Series Fund Inc - Blackrock Balanced Capital Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Value Portfolio | Multi-Cap Value | 217,412 | Added More | 130,912 | 151.34 % | $4,878,725 | $4,826,546 | $-52,179 | -1.06 % | $-31,419 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Value Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | 246,950 | Sold Some | -4,050 | -1.61 % | $5,541,558 | $5,482,290 | $-59,268 | -1.06 % | $972 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqinternational Growth Portfolio | Multi-Cap Growth | | Sold All | -25,496 | -100 % | | | | -1.06 % | $6,119 | | | | | | News Article | History of Eq Advisors Trust - Eqinternational Growth Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | First Trust Exchange Traded Fund - First Trust Value Line Equity Allocation Index Fund | Multi-Cap Value | 1,047 | Sold Some | -2 | -0.19 % | $23,495 | $23,243 | $-251 | -1.06 % | $0 | | | | | | News Article | History of First Trust Exchange Traded Fund - First Trust Value Line Equity Allocation Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust Ii - Jpmorgan Intrepid Mid Cap Fund | Mid-Cap Core | | Sold All | -73 | -100 % | | | | -1.06 % | $18 | | | | | | News Article | History of Jpmorgan Trust Ii - Jpmorgan Intrepid Mid Cap Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Manor Investment Funds Inc - Bond Fund | Specialty & Misc | 4,130 | No Change | 0 | 0 % | $92,677 | $91,686 | $-991 | -1.06 % | $0 | | | | | | News Article | History of Manor Investment Funds Inc - Bond Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Massmutual Select Funds - Massmutual Select Small Company Value Fund | Small-Cap Core | 22,950 | New Holding | 22,950 | 100 % | $514,998 | $509,490 | $-5,508 | -1.06 % | $-5,508 | | | | | | News Article | History of Massmutual Select Funds - Massmutual Select Small Company Value Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Mma Praxis Mutual Funds - Mma Praxis Small Cap Fund | Small-Cap Core | 9,950 | Added More | 2,700 | 37.24 % | $223,278 | $220,890 | $-2,388 | -1.06 % | $-648 | | | | | | News Article | History of Mma Praxis Mutual Funds - Mma Praxis Small Cap Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sbl Fund - Series X | Specialty & Misc | 9,200 | New Holding | 9,200 | 100 % | $206,448 | $204,240 | $-2,208 | -1.06 % | $-2,208 | | | | | | News Article | History of Sbl Fund - Series X Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Institutional Index Funds - Vanguard Institutional Index Fund | Specialty & Misc | | Sold All | -122,494 | -100 % | | | | -1.06 % | $29,399 | | | | | | News Article | History of Vanguard Institutional Index Funds - Vanguard Institutional Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Variable Insurance Funds - Balanced Portfolio | Flexible Portfolio | | Sold All | -47,122 | -100 % | | | | -1.06 % | $11,309 | | | | | | News Article | History of Vanguard Variable Insurance Funds - Balanced Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-04 | 2009-06-10 | N-CSRS | Jpmorgan Insurance Trust - Jpmorgan Insurance Trust Intrepid Mid Cap Portfolio | Mid-Cap Core | | Sold All | -7,850 | -100 % | | | | -1.06 % | $1,884 | | | | | | News Article | History of Jpmorgan Insurance Trust - Jpmorgan Insurance Trust Intrepid Mid Cap Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Advantus Series Fund Inc - Index 400 Mid-Cap Portfolio | No Data | | Sold All | -16,987 | -100 % | | | | 1.74 % | $-6,455 | | | | | | News Article | History of Advantus Series Fund Inc - Index 400 Mid-Cap Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | American Century Quantitative Equity Funds Inc - Utilities Fund | Utility | | Sold All | -7,928 | -100 % | | | | 1.74 % | $-3,013 | | | | | | News Article | History of American Century Quantitative Equity Funds Inc - Utilities Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Jnl Variable Fund Llc - Jnlmcm Healthcare Sector Fund | Health/Biotech | 10 | Sold Some | -1 | -9.09 % | $218 | $222 | $4 | 1.74 % | $0 | | | | | | News Article | History of Jnl Variable Fund Llc - Jnlmcm Healthcare Sector Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Jnl Variable Fund Llc - Jnlmcm Jnl 5 Fund | Specialty & Misc | 30 | No Change | 0 | 0 % | $655 | $666 | $11 | 1.74 % | $0 | | | | | | News Article | History of Jnl Variable Fund Llc - Jnlmcm Jnl 5 Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Jnl Variable Fund Llc - Jnlmcm Vip Fund | Specialty & Misc | 17 | Added More | 1 | 6.25 % | $371 | $377 | $6 | 1.74 % | $0 | | | | | | News Article | History of Jnl Variable Fund Llc - Jnlmcm Vip Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mainstay Vp Series Fund Inc - Vp Common Stock Portfolio | Specialty & Misc | | Sold All | -32,372 | -100 % | | | | 1.74 % | $-12,301 | | | | | | News Article | History of Mainstay Vp Series Fund Inc - Vp Common Stock Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mainstay Vp Series Fund Inc - Vp Mid Cap Core Portfolio | Mid-Cap Core | | Sold All | -51,783 | -100 % | | | | 1.74 % | $-19,678 | | | | | | News Article | History of Mainstay Vp Series Fund Inc - Vp Mid Cap Core Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund Ii - Mml Small Cap Equity Fund | Small-Cap Core | 6,306 | Added More | 5,806 | 1161.20 % | $137,597 | $139,993 | $2,396 | 1.74 % | $2,206 | | | | | | News Article | History of Mml Series Investment Fund Ii - Mml Small Cap Equity Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Northwestern Mutual Series Fund Inc - Index 400 Stock Portfolio | No Data | | Sold All | -50,200 | -100 % | | | | 1.74 % | $-19,076 | | | | | | News Article | History of Northwestern Mutual Series Fund Inc - Index 400 Stock Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pacific Select Fund | Pacific Region | 30,784 | New Holding | 30,784 | 100 % | $671,707 | $683,405 | $11,698 | 1.74 % | $11,698 | | | | | | News Article | History of Pacific Select Fund - Pacific Select Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Large-Cap Value Index Portfolio | No Data | 356 | No Compare | | | $7,768 | $7,903 | $135 | 1.74 % | | | | | | | News Article | History of Pacific Select Fund - Pd Large-Cap Value Index Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | Streettracks Series Trust - Spdr Dividend Etf | Specialty & Misc | | Sold All | -122,542 | -100 % | | | | 1.74 % | $-46,566 | | | | | | News Article | History of Streettracks Series Trust - Spdr Dividend Etf Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Lkcm Funds - Lkcm Aquinas Small Cap Fund | Small-Cap Core | 2,600 | Added More | 600 | 30.00 % | $56,732 | $57,720 | $988 | 1.74 % | $228 | | | | | | News Article | History of Lkcm Funds - Lkcm Aquinas Small Cap Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Met Investors Series Trust - Batterymarch Growth And Income Portfolio | Multi-Cap Growth | 70,700 | No Change | 0 | 0 % | $1,542,674 | $1,569,540 | $26,866 | 1.74 % | $0 | | | | | | News Article | History of Met Investors Series Trust - Batterymarch Growth And Income Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Schwab Capital Trust - Schwab Technology Fund | Science & Tech | | Sold All | -15,410 | -100 % | | | | 1.74 % | $-5,856 | | | | | | News Article | History of Schwab Capital Trust - Schwab Technology Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR | Algert Coldiron Investors Llc | Institution | 85,880 | Sold Some | -120 | -0.13 % | $1,915,983 | $1,906,536 | $-9,447 | -0.49 % | $13 | | | | | | News Article | History of Algert Coldiron Investors Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Amvescap Plc | Institution | 788,081 | Sold Some | -1,600,567 | -67.00 % | $17,582,087 | $17,495,398 | $-86,689 | -0.49 % | $176,062 | | | | | | News Article | History of Amvescap Plc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-01 | 2009-06-30 | N-CSRS | College Retirement Equities Fund - Equity Index Account | Specialty & Misc | 90,528 | New Holding | 90,528 | 100 % | $2,019,680 | $2,009,722 | $-9,958 | -0.49 % | $-9,958 | | | | | | News Article | History of College Retirement Equities Fund - Equity Index Account Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fidelity International Ltd | Institution | 36,100 | New Holding | 36,100 | 100 % | $805,391 | $801,420 | $-3,971 | -0.49 % | $-3,971 | | | | | | News Article | History of Fidelity International Ltd Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fmr Corp | Institution | 11,534,156 | Sold Some | -3,126,085 | -21.32 % | $257,327,020 | $256,058,263 | $-1,268,757 | -0.49 % | $343,869 | | | | | | News Article | History of Fmr Corp Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-09-01 | 2009-06-30 | N-CSRS | Tiaa Separate Account Va 1 - Stock Index Account | Specialty & Misc | 6,595 | No Change | 0 | 0 % | $147,134 | $146,409 | $-725 | -0.49 % | $0 | | | | | | News Article | History of Tiaa Separate Account Va 1 - Stock Index Account Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Diversified Investors Funds Group - Value Fund | Multi-Cap Value | | Sold All | -219,700 | -100 % | | | | -1.63 % | $81,289 | | | | | | News Article | History of Diversified Investors Funds Group - Value Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Diversified Investors Funds Group Ii - Value Fund | Small-Cap Core | | Sold All | -219,700 | -100 % | | | | -1.63 % | $81,289 | | | | | | News Article | History of Diversified Investors Funds Group Ii - Value Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Diversified Investors Portfolios - Value Portfolio | Multi-Cap Value | | Sold All | -219,700 | -100 % | | | | -1.63 % | $81,289 | | | | | | News Article | History of Diversified Investors Portfolios - Value Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Northern Lights Fund Trust - Biondo Fund | Health/Biotech | | Sold All | -390 | -100 % | | | | -1.63 % | $144 | | | | | | News Article | History of Northern Lights Fund Trust - Biondo Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Social Choice Equity Fund | Multi-Cap Core | 500 | No Change | 0 | 0 % | $11,285 | $11,100 | $-185 | -1.63 % | $0 | | | | | | News Article | History of Tiaa Cref Life Fund - Social Choice Equity Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Stock Index Fund | Specialty & Misc | 1,415 | Added More | 50 | 3.66 % | $31,937 | $31,413 | $-524 | -1.63 % | $-19 | | | | | | News Article | History of Tiaa Cref Life Fund - Stock Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Wisdomtree Trust - Wisdomtree Diefa Fund | Specialty & Misc | 613 | Sold Some | -273 | -30.81 % | $13,835 | $13,609 | $-227 | -1.63 % | $101 | | | | | | News Article | History of Wisdomtree Trust - Wisdomtree Diefa Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Wisdomtree Trust - Wisdomtree Total Earnings Fund | Specialty & Misc | 220 | Added More | 17 | 8.37 % | $4,965 | $4,884 | $-81 | -1.63 % | $-6 | | | | | | News Article | History of Wisdomtree Trust - Wisdomtree Total Earnings Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-CSR | Allianz Funds - Occ Value | Large-Cap Value | | Sold All | -450,770 | -100 % | | | | -2.37 % | $243,416 | | | | | | News Article | History of Allianz Funds - Occ Value Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | American Century Capital Portfolios Inc - Small Cap Value Fund | Small-Cap Value | 200,000 | New Holding | 200,000 | 100 % | $4,548,000 | $4,440,000 | $-108,000 | -2.37 % | $-108,000 | | | | | | News Article | History of American Century Capital Portfolios Inc - Small Cap Value Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Calvert Social Index Series Inc - Calvert Social Index Fund | Multi-Cap Core | 1,681 | No Change | 0 | 0 % | $38,226 | $37,318 | $-908 | -2.37 % | $0 | | | | | | News Article | History of Calvert Social Index Series Inc - Calvert Social Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Calvert Social Investment Fund - Equity Portfolio | Multi-Cap Core | 3,201 | Sold Some | -2,699 | -45.74 % | $72,791 | $71,062 | $-1,729 | -2.37 % | $1,457 | | | | | | News Article | History of Calvert Social Investment Fund - Equity Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Calvert World Values Fund Inc - Capital Accumulation Fund | Mid-Cap Growth | 80,600 | Sold Some | -33,600 | -29.42 % | $1,832,844 | $1,789,320 | $-43,524 | -2.37 % | $18,144 | | | | | | News Article | History of Calvert World Values Fund Inc - Capital Accumulation Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Evergreen Equity Trust De - Evergreen Growth Fund | Multi-Cap Growth | | Sold All | -11,069 | -100 % | | | | -2.37 % | $5,977 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Growth Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | First Investors Equity Funds - Special Situations Fund | Small-Cap Value | | Sold All | -237,400 | -100 % | | | | -2.37 % | $128,196 | | | | | | News Article | History of First Investors Equity Funds - Special Situations Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | 495,341 | Sold Some | -32,286 | -6.11 % | $11,264,054 | $10,996,570 | $-267,484 | -2.37 % | $17,434 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 1000 Growth Index Fund | Multi-Cap Growth | | Sold All | -222,135 | -100 % | | | | -2.37 % | $119,953 | | | | | | News Article | History of Ishares Trust - Ishares Russell 1000 Growth Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 1000 Index Fund | Specialty & Misc | 59,995 | Sold Some | -476 | -0.78 % | $1,364,286 | $1,331,889 | $-32,397 | -2.37 % | $257 | | | | | | News Article | History of Ishares Trust - Ishares Russell 1000 Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 1000 Value Index Fund | Multi-Cap Value | 185,800 | Added More | 167,225 | 900.26 % | $4,225,092 | $4,124,760 | $-100,332 | -2.37 % | $-90,302 | | | | | | News Article | History of Ishares Trust - Ishares Russell 1000 Value Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | | Sold All | -7,436 | -100 % | | | | -2.37 % | $4,015 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Growth Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | 33,938 | Added More | 1,980 | 6.19 % | $771,750 | $753,424 | $-18,327 | -2.37 % | $-1,069 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Value Index Fund | Multi-Cap Value | 7,788 | Added More | 7,025 | 920.70 % | $177,099 | $172,894 | $-4,206 | -2.37 % | $-3,794 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Value Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Midcap Growth Index Fund | Mid-Cap Growth | | Sold All | -163,070 | -100 % | | | | -2.37 % | $88,058 | | | | | | News Article | History of Ishares Trust - Ishares Russell Midcap Growth Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Midcap Index Fund | Mid-Cap Core | 176,275 | Sold Some | -19,426 | -9.92 % | $4,008,494 | $3,913,305 | $-95,189 | -2.37 % | $10,490 | | | | | | News Article | History of Ishares Trust - Ishares Russell Midcap Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Midcap Value Index Fund | Mid-Cap Value | 199,566 | Added More | 179,261 | 882.84 % | $4,538,131 | $4,430,365 | $-107,766 | -2.37 % | $-96,801 | | | | | | News Article | History of Ishares Trust - Ishares Russell Midcap Value Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Loomis Sayles Funds I - Loomis Sayles Small Cap Value Fund | Small-Cap Core | 270,162 | Added More | 53,068 | 24.44 % | $6,143,484 | $5,997,596 | $-145,887 | -2.37 % | $-28,657 | | | | | | News Article | History of Loomis Sayles Funds I - Loomis Sayles Small Cap Value Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Loomis Sayles Funds Ii - Loomis Sayles Value Fund | Large-Cap Value | | Sold All | -217,094 | -100 % | | | | -2.37 % | $117,231 | | | | | | News Article | History of Loomis Sayles Funds Ii - Loomis Sayles Value Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Pacific Life Funds - Pl Comstock Fund | Specialty & Misc | | Sold All | -2,760 | -100 % | | | | -2.37 % | $1,490 | | | | | | News Article | History of Pacific Life Funds - Pl Comstock Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Pacific Life Funds - Pl Main Street Core Fund | Multi-Cap Core | 2,660 | New Holding | 2,660 | 100 % | $60,488 | $59,052 | $-1,436 | -2.37 % | $-1,436 | | | | | | News Article | History of Pacific Life Funds - Pl Main Street Core Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Phoenix Aberdeen Worldwide Opportunities Fund - Virtus Capital Growth Fund | No Data | 145,650 | Added More | 33,600 | 29.98 % | $3,312,081 | $3,233,430 | $-78,651 | -2.37 % | $-18,144 | | | | | | News Article | History of Phoenix Aberdeen Worldwide Opportunities Fund - Virtus Capital Growth Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Pioneer Mid Cap Growth Fund - Pioneer Mid Cap Growth Fund | Mid-Cap Growth | 64,000 | New Holding | 64,000 | 100 % | $1,455,360 | $1,420,800 | $-34,560 | -2.37 % | $-34,560 | | | | | | News Article | History of Pioneer Mid Cap Growth Fund - Pioneer Mid Cap Growth Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Rainier Investment Management Mutual Funds - Rainier Balanced Portfolio | Flexible Portfolio | | Sold All | -5,300 | -100 % | | | | -2.37 % | $2,862 | | | | | | News Article | History of Rainier Investment Management Mutual Funds - Rainier Balanced Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Rainier Investment Management Mutual Funds - Rainier Mid Cap Equity Portfolio | Mid-Cap Core | 1,122,206 | New Holding | 1,122,206 | 100 % | $25,518,964 | $24,912,973 | $-605,991 | -2.37 % | $-605,991 | | | | | | News Article | History of Rainier Investment Management Mutual Funds - Rainier Mid Cap Equity Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Rainier Investment Management Mutual Funds - Rainier Smallmid Cap Equity Portfolio | Small-Cap Core | | Sold All | -147,050 | -100 % | | | | -2.37 % | $79,407 | | | | | | News Article | History of Rainier Investment Management Mutual Funds - Rainier Smallmid Cap Equity Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Seasons Series Trust - Mid Cap Value Portfolio | Mid-Cap Value | 3,490 | New Holding | 3,490 | 100 % | $79,363 | $77,478 | $-1,885 | -2.37 % | $-1,885 | | | | | | News Article | History of Seasons Series Trust - Mid Cap Value Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Seasons Series Trust - Small Cap Portfolio | Small-Cap Core | 58,800 | New Holding | 58,800 | 100 % | $1,337,112 | $1,305,360 | $-31,752 | -2.37 % | $-31,752 | | | | | | News Article | History of Seasons Series Trust - Small Cap Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Seasons Series Trust - Stock Portfolio | Multi-Cap Core | 57,443 | New Holding | 57,443 | 100 % | $1,306,254 | $1,275,235 | $-31,019 | -2.37 % | $-31,019 | | | | | | News Article | History of Seasons Series Trust - Stock Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Sti Classic Funds - Balanced Fund | Flexible Portfolio | | Sold All | -42,970 | -100 % | | | | -2.37 % | $23,204 | | | | | | News Article | History of Sti Classic Funds - Balanced Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 946,650 | Added More | 131,437 | 16.12 % | $21,526,821 | $21,015,630 | $-511,191 | -2.37 % | $-70,976 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Horizon Funds - Vanguard Strategic Equity Fund | Specialty & Misc | 155,300 | Added More | 130,500 | 526.20 % | $3,531,522 | $3,447,660 | $-83,862 | -2.37 % | $-70,470 | | | | | | News Article | History of Vanguard Horizon Funds - Vanguard Strategic Equity Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | American National Investment Accounts Inc - Balanced Portfolio | Flexible Portfolio | 900 | New Holding | 900 | 100 % | $20,259 | $19,980 | $-279 | -1.37 % | $-279 | | | | | | News Article | History of American National Investment Accounts Inc - Balanced Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | American National Investment Accounts Inc - Growth Portfolio | Multi-Cap Growth | 2,100 | New Holding | 2,100 | 100 % | $47,271 | $46,620 | $-651 | -1.37 % | $-651 | | | | | | News Article | History of American National Investment Accounts Inc - Growth Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Dws Investment Trust - Dws Small Cap Core Fund | Small-Cap Core | 11,200 | Sold Some | -25,900 | -69.81 % | $252,112 | $248,640 | $-3,472 | -1.37 % | $8,029 | | | | | | News Article | History of Dws Investment Trust - Dws Small Cap Core Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Icon Funds - Icon Healthcare Fund | Health/Biotech | | Sold All | -98,300 | -100 % | | | | -1.37 % | $30,473 | | | | | | News Article | History of Icon Funds - Icon Healthcare Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Janus Aspen Series - Mid Cap Value Portfolio | Mid-Cap Value | 13,500 | No Change | 0 | 0 % | $303,885 | $299,700 | $-4,185 | -1.37 % | $0 | | | | | | News Article | History of Janus Aspen Series - Mid Cap Value Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Mfs Sun Life Series Trust - Mfs Blended Research Growth Portfolio | No Data | | Sold All | -692 | -100 % | | | | -1.37 % | $215 | | | | | | News Article | History of Mfs Sun Life Series Trust - Mfs Blended Research Growth Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Mgi Funds - Mgi Us Large Cap Value Equity Fund | Large-Cap Value | 13,800 | New Holding | 13,800 | 100 % | $310,638 | $306,360 | $-4,278 | -1.37 % | $-4,278 | | | | | | News Article | History of Mgi Funds - Mgi Us Large Cap Value Equity Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Enhanced Large-Cap Growth Index Fund | No Data | 22,164 | Sold Some | -4,236 | -16.04 % | $498,912 | $492,041 | $-6,871 | -1.37 % | $1,313 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Enhanced Large-Cap Growth Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Enhanced Large-Cap Value Index Fund | No Data | 22,167 | Added More | 10,767 | 94.44 % | $498,979 | $492,107 | $-6,872 | -1.37 % | $-3,338 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Enhanced Large-Cap Value Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Equity Index Fund | Specialty & Misc | 26,208 | Added More | 17,138 | 188.95 % | $589,942 | $581,818 | $-8,124 | -1.37 % | $-5,313 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Equity Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Growth Equity Fund | Multi-Cap Growth | | Sold All | -77,021 | -100 % | | | | -1.37 % | $23,877 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Growth Equity Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Social Choice Equity Fund | Specialty & Misc | 13,375 | Added More | 1,455 | 12.20 % | $301,071 | $296,925 | $-4,146 | -1.37 % | $-451 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Social Choice Equity Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard 500 Index Fund | S&P 500 Index | | Sold All | -148,865 | -100 % | | | | -1.37 % | $46,148 | | | | | | News Article | History of Vanguard Index Funds - Vanguard 500 Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | 712,382 | New Holding | 712,382 | 100 % | $16,035,719 | $15,814,880 | $-220,838 | -1.37 % | $-220,838 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Growth Index Fund | Large-Cap Growth | 219,462 | New Holding | 219,462 | 100 % | $4,940,090 | $4,872,056 | $-68,033 | -1.37 % | $-68,033 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Growth Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 1,080,232 | New Holding | 1,080,232 | 100 % | $24,316,022 | $23,981,150 | $-334,872 | -1.37 % | $-334,872 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Value Index Fund | Large-Cap Value | 84,225 | New Holding | 84,225 | 100 % | $1,895,905 | $1,869,795 | $-26,110 | -1.37 % | $-26,110 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Value Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 51,363 | Sold Some | -1,050 | -2.00 % | $1,156,181 | $1,140,259 | $-15,923 | -1.37 % | $326 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 55,189 | Added More | 2,776 | 5.29 % | $1,242,304 | $1,225,196 | $-17,109 | -1.37 % | $-861 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-26 | 2009-06-30 | 13F-HR/A | Duquesne Capital Management L L C | Institution | 145,700 | Sold Some | -54,300 | -27.15 % | $3,273,879 | $3,234,540 | $-39,339 | -1.20 % | $14,661 | | | | | | News Article | History of Duquesne Capital Management L L C Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-26 | 2008-12-31 | 13F-HR | Riverfront Investment Group Llc | No Data | 61,343 | No Compare | | | $1,378,377 | $1,361,815 | $-16,563 | -1.20 % | | | | | | | News Article | History of Riverfront Investment Group Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-25 | 2009-06-30 | N-Q | Cornercap Group Of Funds Va - Cornercap Contrarian Fund | Specialty & Misc | 835 | No Change | 0 | 0 % | $18,621 | $18,537 | $-84 | -0.44 % | $0 | | | | | | News Article | History of Cornercap Group Of Funds Va - Cornercap Contrarian Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-25 | 2009-06-30 | N-Q | Laudus Trust - Laudus Rosenberg International Discovery Fund | Global Flex Port | | Sold All | -101,138 | -100 % | | | | -0.44 % | $10,114 | | | | | | News Article | History of Laudus Trust - Laudus Rosenberg International Discovery Fund Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-25 | 2009-06-30 | N-CSRS | Maxim Series Fund Inc - Maxim Loomis Sayles Small-Cap Value Portfolio | No Data | 72,477 | New Holding | 72,477 | 100 % | $1,616,237 | $1,608,989 | $-7,248 | -0.44 % | $-7,248 | | | | | | News Article | History of Maxim Series Fund Inc - Maxim Loomis Sayles Small-Cap Value Portfolio Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-25 | 2009-06-30 | 13F-HR/A | Riverfront Investment Group Llc | No Data | 129,749 | Added More | 68,406 | 111.51 % | $2,893,403 | $2,880,428 | $-12,975 | -0.44 % | $-6,841 | | | | | | News Article | History of Riverfront Investment Group Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-25 | 2009-03-31 | 13F-HR | Riverfront Investment Group Llc | No Data | 61,343 | No Change | 0 | 0 % | $1,367,949 | $1,361,815 | $-6,134 | -0.44 % | $0 | | | | | | News Article | History of Riverfront Investment Group Llc Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-24 | 2009-06-30 | 13F-HR | Bank Of Albuquerque Na | No Data | 14,285 | No Compare | | | $315,413 | $317,127 | $1,714 | 0.54 % | | | | | | | News Article | History of Bank Of Albuquerque Na Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-24 | 2009-06-30 | 13F-HR/A | Bank Of Oklahoma National Association | No Data | 44,710 | No Compare | | | $987,197 | $992,562 | $5,365 | 0.54 % | | | | | | | News Article | History of Bank Of Oklahoma National Association Ownership Of Endo Pharmaceuticals Holdings Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva | Specialty & Misc | 74,348 | New Holding | 74,348 | 100 % | $1,641,604 | $1,650,526 | $8,922 | 0.54 % | $8,922 | | | | | | News Article | History of Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva Ownership Of Endo Pharmaceuticals Holdings Inc |
RSS feed for ENDP